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Chapter 1
Summary
The regulation of gene expression in eukaryotes is a complex process balancing two oppos-
ing schemes into one regulatory network. Stable maintenance of gene expression patterns
is as important as quick adaption to intrinsic and extrinsic stimuli. Over the past years it
has emerged that gene regulation is a multistep process occurring at many levels. On the
level of DNA and chromatin it is determined how efficiently a gene is transcribed by RNA
polymerase II (RNAP II) in the first place. Influenced by many processing steps, which are
mediated amongst others by RNA binding proteins (RBPs), only a fraction of a respective
gene arrives to the cytoplasm, where more regulatory processes alter the lifetime of mes-
senger RNA (mRNA), during which it is available for translation into protein. Due to the
local separation of nucleus and cytoplasm in eukaryotes it is intuitive to imagine a stepwise
process, which can be split up in transcriptional regulation in the first place and subsequent
post-transcriptional regulation.
At the beginning of my PhD high resolution genome-wide data of chromatin modifications
[Barski et al., 2007; Mikkelsen et al., 2007] and transcription [Mortazavi et al., 2008; Wang
et al., 2009] became available, which allowed a global correlation of mRNA expression with
chromatin features. Also supported through RNA sequencing data, more small regulatory
RNAs were discovered and their expression linked to specific cell types [Carninci, 2009; Core
et al., 2008; Seila et al., 2008; Wang et al., 2009]. Both, histone marks influencing the
chromatin environment and post-transcriptional processes operating on RNA level, have a
contribution to the final mRNA concentration per gene in a cell. It was still largely unknown
if these processes are separable and how much each process contributes to the final mRNA
expression.
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1. SUMMARY
Therefore we set out to define the relative contributions of transcriptional and post-transcriptional
regulation which shape the mRNA profile in a cell. To this end we obtained all necessary
data from murine embryonic stem cells, which are differentiated into neurons in cell cul-
ture. Modifications at histone H3 (di-methylation of lysine 4 at histone tail H3 (H3K4me2),
tri-methylation of lysine 27 at histone tail H3 (H3K27me3) and tri-methylation of lysine
36 at histone tail H3 (H3K36me3)) and RNAP II occupancy were derived by chromatin
immunoprecipitation (ChIP) followed by deep sequencing to predict transcription rate. In
addition we measure mRNA decay rates of protein coding genes both, by transcription arrest
and pulse labeling and infer expression profiles of micro RNAs (miRNAs) during neuronal
differentiation by small RNA sequencing.
Our integrative analysis in ESC revealed that chromatin marks are very good predictors
of steady-state mRNA level. Especially, H3K36me3, which is a co-transcriptional histone
mark, is highly correlated with mRNA abundance when integrated over the whole gene
body. This is in contrast to two other studies [Cheng and Gerstein, 2011; Karlic et al.,
2010], which also use histone marks to predict mRNA expression, however because their
analysis is restricted to regions around the TSS, they do not use the full predictive power
of the H3K36me3. Here we show that with H3K36me3, additional two promoter proximal
histone marks and RNAP II occupancy, we can explain most of the variance in mRNA levels
(∼85%). Based on this result we went on to ask which regulatory mechanism could explain
the additional variance in transcript levels, and investigated the contribution of mRNA de-
cay to steady-state levels in general and in particular focus on miRNA-mediated degradation
of transcripts.
This analysis, integrating mRNA half-life of each transcript in a model together with
transcription-relevant measures, shows, that degradation has a minor quantitative impact
on mRNA levels (<2%). This is in accordance with two recent publications in murine fi-
broblast and dendritic cells [Rabani et al., 2011; Schwanha¨usser et al., 2011], which show,
by measuring mRNA transcription rate and modeling RNA decay, a similar ratio of tran-
scriptional and post-transcriptional regulation to quantify mRNA levels. Furthermore, we
were interested in the quantitative contribution of mRNA degradation, which is mediated
by miRNAs specifically. To this end we established weighted miRNA-target connections by
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combining a posterior probability score [Gaidatzis et al., 2007] of interaction with experi-
mentally inferred miRNA expression data. On a subset of likely miRNA target genes we can
see a small effect of miRNA-mediated post-transcriptional decay, however on a genome-
wide level the quantitative contribution of this regulatory layer is too small to be detectable.
Together, our findings establish a chromatin-based quantitative model for the contribu-
tion of transcriptional and post-transcriptional regulatory processes to steady-state levels
of messenger RNA and support the recent notion that the lion share of mRNA expression
regulation is happening at the level of transcription [Rabani et al., 2011; Schwanha¨usser
et al., 2011].
3
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Chapter 2
Introduction
Every multicellular organism originates from a single fertilised egg. During metazoan de-
velopment this single cell divides and gives rise to many specialised cell types with different
phenotypes and functions. While the genetic information of these cells is a constant, their
set of expressed genes is subject to major changes throughout differentiation. This process
requires the coordinated regulation of gene expression, which is a complex, multi-layered
process in eukaryotes. Gene expression regulation describes the whole processes, that cells
use to regulate the way that information in genes is turned into gene products. At any step
the gene’s expression may be modulated, from transcription of the DNA to RNA, during
splicing, export to the cytoplasm, before, during and after translation. While there is a
fairly good understanding of the mechanistic details of each of the regulatory processes, the
interaction between them has not been studied until recently.
In bacteria regulatory pathways from DNA over RNA to protein are often directly coupled
due to the lack of a compartmentalisation [Montero Llopis et al., 2010]. Coupling, in a
non-direct way, might also occur in eurkaryotes [Dahan et al., 2011], however we can dis-
tinguish processes that happen in the nucleus from cytoplasmic events.
The following paragraphs will summarize current knowledge on transcriptional regulation
of RNA synthesis and post-transcriptional down-regulation of mRNA. I will also introduce
quantitaive measures that provide potential readouts of these regulatory layers, relating to
my PhD thesis project.
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2.1 Transcriptional Gene Regulation
Throughout evolution, complexity of organisms scales with genome size. Paradoxically, the
number of genes does not match up with this increase in size and complexity, a phenomenon
termed the c-value enigma [Gregory, 2001]. The mouse genome for example is 240 times
bigger than budding yeast saccharomyces cerevisiae, however it encodes only 4 times more
proteins (23,000 genes in mouse [Waterston et al., 2002] vs 5,500 in yeast [Kellis et al.,
2003]). This raises the question, how is complexity achieved? One explanation is the
number of transcription factor (TF) genes, which increases exponentially (exponent=1.26)
with the number of total protein coding genes in an eukaryotic organism [van Nimwegen,
2003]. TFs are the most prominent and best studied mediators for gene expression regula-
tion [Vaquerizas et al., 2009]. Their recognition motifs are on average 6-8 bp in length, in
prokaryotes as well as in and eukaryotes, and in many cases the binding motifs are degen-
erate [Wray et al., 2003]. In large vertebrate genomes however, where only a small portion
encodes proteins or regulatory RNAs [Waterston et al., 2002] this poses a major challenge:
in the mouse genome for example, assuming a random sequence distribution, any potential
6-mer motif could bind more than 732,400 times. From ChIP-sequencing experiments we
know that the actual number of sites bound by a TF in a cell is considerably smaller. Com-
binatorial regulation of transcription factors [Bilu and Barkai, 2005] could possibly confer
specificity of TF binding, but further structuring of large genomes is required to guide the
TFs to their respective target sites and thereby reduce random binding.
Chromatin modifying mechanisms co-evolved with genome size: although the use of chro-
mosomal architectural proteins variants is conserved back to eubacteria, in the transition
from pro- to eukaryotes, mechanisms for ’writing’ chemical modifications, that constitute
persistent signals, onto chromatin appeared [Prohaska et al., 2010].
In the following sections I will give an overview of cellular processes that contribute to
transcriptional regulation on the level of chromatin in eukayotes.
2.1.1 DNA, Histones and Chromatin
Roughly two meters of DNA are in the nucleus of every mammalian cell. For obvious pack-
aging but also regulatory purposes the DNA is highly compacted, where the chromosome
represents the highest compaction form. The chromosome is composed of a highly folded
6
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30 nm chromatin fibre of packaged nucleosomes. Nucleosome structure, so called ’beads on
a string’, consists of DNA wrapped around histones thereby achieving a high initial conden-
sation (Figure 2.1). Nucleosomes consist of approximately 150 bp of DNA wrapped around
Figure 2.1: Model of chromatin compaction of DNA in the nucleus depicts the DNA double-strand,
which is wrapped around histone proteins to form the nucleosome. This ’beads on a string’ structure
of nucleosomes is then further compacted into a 30nm fiber with the help of linker histone H1 and
even more condensed on further scaffold proteins leading to a chromosome structure.
a protein octamer of four core histones, H3, H4, H2A and H2B [Kornberg and Thomas,
1974]. Together with so called linker histones (H1), this results in a more than 50-fold
compaction of the genome in the nucleus of the cell, termed chromatin (Figure 2.1). In
addition to packaging this chromatin conformation also allows to make DNA more or less
accessible for TFs to bind. The tight structure of DNA wrapped around histones is in itself
rather in-accessible [Lam et al., 2008; Struhl, 1999; Workman and Kingston, 1998].
Alteration of core histone stoichiometry in yeast leads to constitutive activation of many
7
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inducible genes (Han and Grundstein 1988). This provides support for the repression of
basal transcription through chromatin assembly. Chemical modifications on histone tails
lead to recruitment of non-histone proteins or directly influence the electric charge of the
chromatin and can thereby pull nucleosomes closer together or push them apart (Figure
2.1). This regulates the access of TFs and ultimately the transcription machinery to the
DNA and renders the chromatin either permissive or repressive for transcription.
2.1.2 DNA Methylation
In theory, a methyl group can be added to any of the 4 nucleic acids, making it a methyl-
A, methyl-G, methyl-T or methyl-C. However, in eukaryotes DNA methylation is exclu-
sively found at cytosine residues. Not all eukaryotes methylate their genomes, for example
yeast and the roundworm C. elegans contain no methylated cytosines at all [Antequera
et al., 1984; Simpson et al., 1986], while all vertebrates seem to display genome-wide DNA
methylation which, in mammals, mostly occurs in the context of CpG dinucleotides [Suzuki
and Bird, 2008]. Genome-wide studies revealed a bimodal distribution of CpG methylation,
with most of the genome being highly methylated (that is 80-100% methylation) and a
few regions largely devoid of methylation, which correspond to relative local enrichments
of CpG dinucleotides, called CpG islands [Bird, 1986]. CpG islands mainly co-localize with
promoters, the transcription regulatory unit of a gene. Recently, however our laboratory
identified novel regions, which are not CpG islands but which nevertheless have low methy-
lation levels, termed low methylated regions (LMRs) [Stadler et al., 2011].
DNA Methylation and Transcription
Early studies in mouse and cancer cells lines connected DNA methylation with X-inactivation,
imprinting and transposon silencing and led to the common theme that DNA methylation
functions to maintain a repressed chromatin state and silence promoter activity [Bird and
Wolffe, 1999; Suzuki and Bird, 2008]. Although it was not initially appreciated that DNA
methylation could be a transient mark, large-scale studies revealed that many promoters
and LMRs vary in their DNA methylation according to cell type [Bibikova et al., 2006;
Eckhardt et al., 2006; Mohn et al., 2008; Rakyan et al., 2004; Rollins et al., 2006; Stadler
et al., 2011; Weber et al., 2007]. The results showed that the majority of the analyzed
8
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regions do not show a continuum of CpG methylation levels. Instead they were either hy-
pomethylated (less than 30% of CpG sites) or hypermethylated (more than 70% of CpG
sites), suggesting two alternative states: silent and methylated or active and unmethylated.
The effect of DNA methylation on gene transcription seems to depend on the CpG con-
tent of the promoter. Single gene studies suggested that methylated, CpG-poor promoters
can repress transcription [Boyes and Bird, 1992; Schu¨beler et al., 2000]. Genome-wide
measurements of DNA methylation showed that some CpG-poor promoters are methylated,
even when the corresponding gene is actively transcribed [Ball et al., 2009; Meissner et al.,
2008; Weber et al., 2007]. In contrast to CpG-poor promoters, DNA methylation at pro-
moters with high CpG content, is clearly anti-correlated with transcription of the associated
gene [Weber et al., 2007]. Two models have been proposed, for the mechanism, by which
the transcriptional inhibition occurs [Appanah et al., 2007; Schu¨beler et al., 2000], however
both act at the level of transcription initiation: One model postulates that DNA methylation
inhibits the binding of methylation-sensitive TFs, the second model is more indirect where
proteins specifically binding to methylated CpGs recruit co-factors, which in turn repress
transcription. For most known methyl-CpG-binding domain proteins (MBDs) an interaction
with factors that set up a repressive chromatin environment has been reported. A variety
of such MBDs are known and for most of these proteins, it has been reported that they
interact with factors that set up a repressive chromatin environment such as HDACs and
the NURD complex [Clouaire and Stancheva, 2008]. However, not only promoter proximal
DNA methylation has an influence on gene expression: A recent study reported regions
with intermediate CpG content, that have low methylation levels and are cell-type specific.
These loci are likely to be distal regulatory regions and are occupied by cell type specific
TFs [Stadler et al., 2011].
2.1.3 Histone Modifications
Histones consist of a globular center and flexible arms, protruding from the center, called
’histone tails’, which have many basic, or positively charged, amino acids (Figure 2.2). It
was found that removal of histone tails from the nucleosome with the protease trypsin fa-
cilitates binding of TATA binding protein (TBP) [Godde et al., 1995] and other TFs [Lee
et al., 1993] and causes specific effects on gene expression [Kayne et al., 1988]. This lead
to the conclusion that the N-terminal tails of the core histones have an important role in
9
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regulating TF access to the DNA [Godde et al., 1995]. Importantly N-terminal tails of hi-
stones are targets for enzymes that modify chromatin structure. Modifications on histones
take place on the N-terminal tails, mostly of histone H3 and H4, which stick out from the
nucleosome core. They contain more than 60 sites which are subject to post-translational
modificationss (PTMs) such as acetylation, methylation, ubiquitination, phosphorylation,
sumoylation and others [Kouzarides, 2007] (methylations and acetylations of N-terminal
tails illustrated in Figure 2.2). Later studies revealed that PTMs are highly dynamic and
have a regulatory role [Brownell et al., 1996; Rea et al., 2000; Taunton et al., 1996].
Modifications associated with active transcription, such as acetylation of histone 3 and
histone 4 or di- and tri-metylation of H3K4, are termed euchromatic modifications, whereas
modifications localized to inactive genes, such as H3K9 methylation and H3K27 methyla-
tion are referred to as heterochromatic modifications (reviewed in Li et al. [2007]). The
concept is sketched in Figure 2.3. In the following subsections I will briefly discuss active
(euchromatin) and repressive (heterochromatin) histone modifications and especially high-
light the histone lysine methylations, H3K27, H3K4 and H3K36, which will be important
for my thesis.
Histone Acetylation
Histone acetylation, similarly to the removal of histone tails, alters the constraints on the
wrapping of DNA on the nucleosome [Bauer et al., 1994] and reduces the stability with
which these flexible domains bind to DNA [Cary et al., 1982]. Histone acetylation neutralises
the charge of nucleosomes, thereby destabilizes nucleosomes, increases DNA accessibility
and leads to non-histone protein binding to DNA in vitro [Imbalzano et al., 1994; Lee et al.,
1993; Vettese-Dadey et al., 1996]. Since transcriptional co-activators in yeast and human
have the capacity to acetylate histones [Brownell et al., 1996], an attractive hypothesis is
that targeted histone acetylation followed by the disruption of chromatin will have a major
causal role in gene regulation [Wolffe and Pruss, 1996]. Acetylated lysines on histones H2B,
H3 and H4 are largely overlapping and highly correlated with active transcribed regions in
yeast [Pokholok et al., 2005], fly [Schubeler et al., 2004] and human [Wang et al., 2008].
With the exception of H4K16 acetylation, which directly interferes with higher order chro-
matin structure [Shogren-Knaak et al., 2006], acetylation of individual lysines conveys little
10
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Figure 2.2: A nucleosome is composed of a protein octamer consisting of the four core histones, H3,
H4, H2A and H2B and the double stranded DNA. C- and N-terminal histone tails of the core histones
can be modified, here only lysine modifications, methylations and acetylations, are depicted. The linker
histone H1 aids in compaction of the chromatin.
specificity. It is rather the cumulative effect of acetyl groups at multiple lysines which is
important for regulating DNA accessibility.
Histone Methylation
In contrast to acetylation, histone methylation is often catalyzed by a specific enzyme at
a specific site and results in unique functions. Methylation of histones can either occur
at lysine or arginine residues. The same residue can exist in mono- (me1), di- (me2) or
tri-methylation state (me3) state which adds another level of regulatory potential. Sev-
eral lysines display diverging functions and localization in the genome depending on their
methylation state (Barski et al., 2007; Peters and Schubeler, 2005).
ChIP experiments showed that active genes are methylated at lysine 4 and 79 of histone H3
(H3K4and H3K79) and lysine 36 of histone H3 (detailed introduction to H3K36me, in sec-
tion 2.1.5) [Barski et al., 2007; Pokholok et al., 2005; Schubeler et al., 2004], therefore these
modifications are thought to have a role in transcription. H3K36me and H3K79me display
11
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a broader distribution within the gene body, while H3K4 methylation states show a distinct
promoter proximal profile: K4me3 peaks at start sites, K4me2 and K4me3 downstream of
the transcription start site (TSS) [Li et al., 2007; Pokholok et al., 2005]. H3K4 methylation
can be bound by chromatin remodelling complexes and different histone acetyltransferases,
creating accessible chromatin and may thereby directly contribute to transcription initia-
tion [Santos-Rosa et al., 2003; Taverna et al., 2006]. Although H3K4me3 can be directly
bound by the general transcription factor TFIID and thereby might facilitate transcription
[Vermeulen et al., 2007], it is not exclusively located at transcribed regions in mammals.
Recent data indicates that in contrast to invertebrates H3K4me2/3 are not exclusively
marking actively transcribed regions, depending on the CpG content of the promoter this
mark correlates with low or high levels of RNAP II [Bernstein et al., 2006; Guenther et al.,
2007; Mikkelsen et al., 2007; Roh et al., 2006; Weber et al., 2007].
An additional mark shown to be enriched at transcribed genes is H3K79 methylation
[Schubeler et al., 2004]. All three methylation variants of H3K79 are catalyzed by DOT1,
the only lysine histone methyl-transferase (HMT) that does not contain a SET domain [van
Leeuwen et al., 2002]. The role of this modification in regulation of transcription, however,
remains still unclear.
In yeast, a second HMT, named SET2, mediates H3K36 methylation, another mark asso-
ciated with transcription. Upon methylation of H3K36, the histone deacetylase complex
Rpd3 removes acetylation [Keogh et al., 2005], which has been suggested to be involved in
preventing spurious transcription [Carrozza et al., 2005]. In Section 2.1.5 I will introduce
H3K36me3 and it’s role in transcription in more detail.
Inactive loci display a different set of methylation marks mainly consisting of methylation of
H3K9, H4K20, and H3K27. H3K27 di- and tri-methylation predominantly localizes to CpG-
rich regions and is excluded from regions carrying H3K9 methylation. H3K27me3 is known
as a mechanistic intermediate during transcriptional repression by polycomb-group (PcG)
proteins. Polycomb-mediated repression is carried out by the two polycomb-repressive-
complexes PRC2 and PRC1. While PRC2 sets the H3K27me3 mark, PRC1 is thought to
be the reader protein, which in turn ubiquitinates lysine 119 at histone H2A [Simon and
Kingston, 2009]. The two PRC complexes are thought to mediate repression by inhibiting
chromatin remodeling, blocking transcription and/or by mediating chromatin compaction
[Margueron et al., 2008].
12
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Figure 2.3: The figure demonstrates two different states of chromatin: active, accessible chromatin
(left) and inactive, ’closed’ chromatin (right). Each state is accompanied by characteristic modifications
of histone tails. Here only two representative histone marks are depicted: H3K4me2 at accessible
chromatin and H3K27me3 at closed chromatin.
PcG proteins and H3K27me3 occupy many inactive promoters of key developmental regu-
lators in embryonic stem (ES) cells, suggesting that they maintain pluripotency and cellular
identity in these cells [Boyer et al., 2006]. Also in later steps of differentiation PcG proteins
were shown to play an important role [Ezhkova et al., 2009; Mohn et al., 2008].
2.1.4 RNA Polymerase II and Transcription
The first step, at which the expression level of genes is regulated in eukaryotes, is RNA
transcription in the nucleus of the cell. RNAP II is the enzyme that transcribes all genes
encoding mRNA as well as as some structural or regulatory RNAs. A feature which distin-
guishes RNAP II from the other two eukaryotic RNA polymerases is the extended carboxyl-
terminal domain (CTD) of the largest RNAP II subunit Rpb1. The 52 copies of the CTD
are subject to modifications during the transcription cycle. While serine 5 phosphotylation
of the CTD is indicative of pausing the serine 2 phosphorylated form is characteristic for
elongating polymerase [Phatnani and Greenleaf, 2006]. The phosphorylation affects the
CTD’s conformation and ability to associate with factors involved in elongation, RNA pro-
cessing and termination of transcription (reviewed in Saunders et al. [2006]).
13
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Initiation of Transcription
Before transcription initiates RNAP II is positioned at the core promoter by a combination of
the general transcription factors (GTFs) TFIID, TFIIA and TFIIB to form the pre-initiation
complex (PIC) [Thomas and Chiang, 2006]. TFIIH then melts 10-15bp of the DNA in order
to position the single stranded template of RNAP II to initiate RNA synthesis. RNAP II
CTD gets phosphorylated at serine 5 during the first 30 bp, before elongation starts. The
phosphorylated CTD then recruits factors important for productive elongation and mRNA
processing [Buratowski, 2003] to the transcription machinery.
Even though this appears straight forward, the rate of transcription is subject to regula-
tion at each of these steps: A study using model fitting based on photo-bleeching and live
imaging in a human cell line, predicted that only 13% of RNAP II, which interacts with
the promoter, are delivered to the initiation step and only 8.6% of these RNAP II engage
in productive elongation [Darzacq et al., 2007]. In total this means that on average only
one RNAP II out of 90 interaction events produces a mature mRNA molecule, suggesting
a tight transcriptional regulation.
The packaging of DNA into chromatin contributes largely to this tight regulation, from
activator binding over PIC formation to productive elongation. A prominent example is the
PHO5 promoter in yeast, which contains one exposed binding site for the TF Pho4 located
in the linker DNA between two nucleosomes, while additional binding sites are buried within
nucleosomes [Adkins et al., 2004; Almer and Ho¨rz, 1986; Boeger et al., 2004]. During in-
duction, Pho4 binds to the accessible site first, recruits proteins which modify histones and
remodel nucleosomes, and thereby expose the secondary binding sites to the TF.
Since the chromatin conformation of DNA is already repressive in itself, regions of active
transcription need to be relieved of condensation. Indeed in yeast it has been shown, that
highly transcribed genes have a lower nucleosome occupancy than intergenic regions, with
pronounced nucleosome depletion in promoter regions [Pokholok et al., 2005]. But not
only at the initiation step, chromatin needs to be de-condensed, also during transcription
elongation the barrier posed by nucleosomes in the coding regions, has to be overcome,
either by completely dis- and reassembling nucleosomes or by modifying histone tails.
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Elongation of Transcription
Recent studies have challenged that transcription is predominantly regulated at the level of
RNAP II binding and initiation and it is now apparent that regulation at the elongation step
is equally important [Min et al. [2011], also reviewed in Saunders et al. [2006]]. Elongation
is divided into three distinct stages: promoter escape, promoter proximal pausing and pro-
ductive elongation. Each of these stages involves a different behavior and stability of the
transcription complex and a specific manipulation of the chromatin environment.
Promoter escape begins after the assembly of the PIC and with the onset of transcription
initiation, from this point the transcription complex is termed the initially transcribing com-
plex (ITC). If RNAP II is subjected to other challenges, the ITC can still abort the nascent
RNA until about 23 bp downstream of the promoter [Pal and Luse, 2003]. Promoter es-
cape is considered complete and the ITC becomes an early elongation complex (EEC) when
the Rpb7 subunit of RNAP II stably associates with the nascent RNA [Ujva´ri and Luse,
2006]. The nascent RNA can also bind the CTD, which might affect transcription elonga-
tion [Kaneko and Manley, 2005].
Another step, other than RNAP II recruitment or transcription initiation, is rate limiting and
a target of regulation: promoter proximal pausing. This is an event in which the forward
movement of elongation competent transcription complexes is temporarily blocked owing
to template sequence, regulatory factors or both. High-resolution analysis showed that the
pausing occurs at several sites from +20 to +40 [Giardina et al., 1992; Rasmussen and
Lis, 1993]. Pausing can provide a checkpoint to assess whether the RNAP II is correctly
prepared for productive elongation, and allows rapid regulation of gene expression. Capping
enzyme associates with the Ser5-phosphorylated CTD of RNAP II [Wen and Shatkin, 1999],
and the nascent RNA becomes capped during elongation through the pause site [Rasmussen
and Lis, 1993]. The phosphorylated CTD stimulates capping enzyme activity in vitro [Wen
and Shatkin, 1999]. Promoter proximal pausing might facilitate correct capping, and a
correctly capped nascent RNA might be a prerequisite for escape from the pause [Pei et al.,
2003].
Several factors are required for the efficient release of paused RNAP II into productive elon-
gation, after which RNAP II proceeds through the remainder of the gene. This is proposed
to occur by the action of the positive transcription-elongation factor-b (P-TEFb) complex.
P-TEFb phosphorylates factors facilitating the paused state, DSIF, NELF and Ser2 of the
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RNAP II CTD [Yamada et al., 2006]. Upon transition to productive elongation DSIF re-
mains associated but NELF leaves the elongation complex [Wu et al., 2005].
Termination of Transcription
Finally, termination of transcription requires the dissociation of RNAP II and the transcrip-
tion complex from the template. This may occour either through a conformational change
in RNAP II following transcription of the poly(A) site [Zhang and Gilmour, 2006] or by an
RNA exonuclease mediated degradation of mRNA, that is still associated to RNAP II and
thereby stimulates its termination (’torpedo model’ Luo and Bentley [2004]).
2.1.5 Readout of Transcription: H3K36me3
The presence of elongating RNAP II is the sign of active transcription of genes, however,
by common methods, such as ChIP, the moving enzyme is hardly detectable along the gene
body. A more stable readout for transcription would therefore be a histone modification,
which is set co-transcriptionally: H3K36me3.
In yeast all three H3 lysine 36 methylation marks, mono-, di- and tri-methylation are me-
diated by the non-essential SET domain-containing (Set2) protein. It associates with the
large subunit of RNAP II (Rpb1) in its hyperphosphorylated form during transcriptional
elongation and deposits the trimethyl group onto H3K36 [Kizer et al., 2005; Li et al., 2003,
2002; Xiao et al., 2003]. In addition the RNAP II, CTD kinase 1 (Ctk1) and the elonga-
tion factor Spt6 regulate the levels of H3K36 tri- but not di-methylation [Lin et al., 2010;
Youdell et al., 2008].
In metazoa the lysine 36 methytransferases are essential and specific for each level of methy-
lation. H3K36 mono- and di-methylation are set by nuclear receptor binding SET domain
protein 1 (NSD1) in human [Lucio-Eterovic et al., 2010], shown through enzymatic essays
[Li et al., 2009] and structural data [Qiao et al., 2011]. Maternal effect sterile 4 (MES-
4) is the NSD1 orthologue in fly [Bell et al., 2007] and worm [Bender et al., 2006], and
although it exclusively sets mono- and di-methyl groups it indirectly regulates the H3K36
tri-methylation by adjusting the availability of substrates to the tri-methylating enzymes.
In worm and fly the tri-methylating enzymes are termed histone-methyltransferase-like 1
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(MET-1) [Andersen and Horvitz, 2007] and Set2 [Bell et al., 2007] respectively. The hu-
man orthologue SET domain-containing 2 (SETD2) (aka HYPB or KMT3A) indeed requires
the NSD1 mediated substrate of H3K36me2 [Edmunds et al., 2008] to set tri-methylation.
It was shown that even with normal levels of H3K36me2 a depletion of SETD2 results in
reduced H3K36me3 levels [Yuan et al., 2009].
Similarly to yeast Set2, human SETD2 interacts with RNAP II during elongation to target
H3K36 [Sun, 2005; Yuan et al., 2009]. This interaction is also regulated by the phos-
phorylated residues in the CTD of Rpb1. During elongation heterogeneous nuclear RNAs
(hnRNAs), including precursors and mature mRNA, associate with specific proteins to form
heterogenous ribonucleoprotein (hnRNP) complexes. Knockdown analyses of one of those
proteins, heterogenous ribonucleoprotein L (hnRNPL), revealed decreased levels of H3K36
tri- but not mono- or di-mathylation [Yuan et al., 2009], indicating that hnRNPL interacts
with SETD2 during active transcription.
It was shown in single gene experiments [Bannister et al., 2005; Edmunds et al., 2008;
Vakoc et al., 2006] as well as genome-wide studies [Barski et al., 2007; Bell et al., 2007;
Mikkelsen et al., 2007; Pokholok et al., 2005] that H3K36me3 levels are correlated with
the expression of active genes. In metazoan and yeast H3K36me3 has a characteristic dis-
tribution pattern increasing towards the 3’ ends of transcription units [Barski et al., 2007;
Bell et al., 2007; Pokholok et al., 2005] . In chicken, there is a shift from mono- to tri-
methylation of H3K36 from the promoters to the 3’ ends of active genes [Bannister et al.,
2005]. Consistent with a role for H3K36me in transcription, data from yeast denote that
H3K36me prevents cryptic initiation via recruiting a histone deacetlyase to the body of
genes, which in turn presumably leads to a less accessible chromatin structure (Carrozza et
al., 2005).
Several large-scale bioinformatic studies have analysed both the positions of nucleosomes
and their modification status within the genomes of humans, C. elegans, D. melanogaster
and mice [Kolasinska-Zwierz et al., 2009; Schwartz et al., 2009; Spies et al., 2009].
In each case, nucleosomes were enriched specifically at exonic sequences. Although the
increased deposition of nucleosomes at exons guarantees a bias in histone modifications
within exons relative to those within introns, it is also clear that a subset of modifictions is
specifically enriched here. This is particularly true for H3K36me3 but also includes methy-
lation at H3K79, H4K20 and H2BK5 [Schwartz et al., 2009]. Each analysis also found
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that the H3K36me3 bias is more pronounced within exons further downstream of the tran-
scription start site. However it is subject to debate whether there is a causal relationship
between the histone modification and the exonic position and if yes, which is cause and
which is consequence [Kim et al., 2011; Schwartz et al., 2009]
Bioinformatic Aspects of H3K36me3 as a Readout
For our study we use H3K36me3 as a readout of transcription. To this end, chromatin
is isolated and fragmented. DNA fragments which are associated with histones carrying
H3K36me3 are enriched by ChIP and analyzed by deep-sequencing on an Illumina GA II.
The raw data obtained by deep sequencing are ∼80 million sequence strings (’reads’) of size
36nt. To obtain a quantitatively meaningful H3K36me3 level per gene, some processing
steps need to be considered. We initially, filtered low-complexity reads based on their
dinucleotide entropy, which is calculated by:
H =
∑
i
filog(fi),
where fi is the frequency of dinucleotide i in the read and the
∑
is over all dinucleotides (i
from 1 to 16). Reads were filtered out if H was less than half the dinucleotide entropy of
the genome, typically removing less than 0.5% of the reads in the given sample. In order to
assign H3K36me3 enrichments to genes, the reads have to be mapped to their respective
position in the genome. A read can possibly map to each position in the mouse genome,
which is 3*109 bases in size. A brute-force approach to the mapping problem would there-
fore in the worst case require 80 million times 3*109 pairwise comparisons, which even with
the fast development of computational hardware, would be too time intensive. To over-
come this limitation the concept of suffix trees is applied, which was introduced in the 70s
by Weiner [Weiner, 1973] and later speed-up by Ukkonen [Giegerich, 1997]. The genome
is decomposed into a ’tree structure’ for once and subsequently each read mapping event
runs in the time of the read length. In addition this allows to even map reads, which have
mismatches (e.g. due to sequencing errors) to their locations in the genome. Alignments
to the mouse genome allowing two mismatches per read were performed by the software
bowtie, which implements this algorithm [Langmead et al., 2009]. Due to repeat elements
and pseudogenes a read can possibly map to multiple locations in the genome, which all
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have the same probability to be the origin of this read. We therefore allow a read to map
up to 100 times not to restrict our analysis to uniquely mapping reads. In addition to track
genomically untemplated hits (e.g., exon-exon junctions), the reads were also mapped to
an annotation database containing known mouse sequences. To account for the multiple
assignment of reads each alignment was weighted by the inverse of the number of hits for
this read. All further quantifications were based on weighted alignments. To quantify the
level of H3K36me3 per gene we had to ensure that that the signal was not blurred by an-
tisense transcripts or overlapping genes with a shifted TSS. For illustration of this problem
assume we want to relate the H3K36me3 level of a region in the genome with the mRNA
level of a gene transcribed from this region (from one specific strand). The ChIP data in-
herently lacks information about the strand because the IP is done on double stranded DNA
bound to histones, however the RNA sequencing data is specific for one strand. To exclude
that we do not associate transcript abundance with H3K36me3 signal from an overlapping
gene location, we stringently excluded based on annotation all mRNA transcripts, which
either overlap with another transcript on the complementary strand or with an overlapping
transcript on the same strand but shifted TSS. In addition we had to consider that there
may be several annotated transcript variants of a gene due to alternative splicing, therefore
we selected the transcript version of median length to be the ’representative’ transcript of
this gene. These filtering steps left us with around 10.000 genes, distant enough to other
transcripts to be safely quantified as separate entities. For those transcripts H3K36me3
reads were summed up over the whole gene body and divided by the length of the gene, to
yield a H3K36me3-density per gene. This density was later logarithmically transformed for
use in the linear regression.
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2.2 Co- and Post-Transcriptional Gene Regulation
For many years, it has been assumed that transcriptional regulation of genes is the ma-
jor source of differential gene expression. However, it becomes more and more evident,
that transcriptional regulation can only partly explain why and at what level proteins are
expressed. Accordingly, quantitative mRNA expression studies are insufficient to predict
protein levels [Gygi et al., 1999].
As co-transcriptional gene regulation I will refer to all mechanisms targeting the transcript
once RNA polymerase has started to transcribe until it releases the mRNA. Following this
scheme, post-transcriptional control of gene expression begins with transcription termi-
nation in the nucleus and extends over mRNA export to all effects, which alter mRNA
abundance in the cytoplasm of the cell before translation into protein.
2.2.1 Co-transcriptional RNA processing
Co-transcriptionally, several processing steps have to take place to transform the pre-mRNA
into mature mRNA: capping, splicing and poly-adenylation (Figure 2.4). Consequently the
complexes that mediate this mRNA processing have to be tightly linked in space and time
to the transcription machinery [Proudfoot et al., 2002], which in turn makes them equally
dependent in chromatin.
Figure 2.4: RNA processing happens co-transcriptional. The CTD of the RNAP II serves as a scaffold
for modifying enzymes which aid in capping, RNA splicing and poly-adenylation.
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5’ End Processing: Capping
The first RNA processing event to occur on the nascent transcript is 5’ end capping, which
happens within the first 40 nucleotides. Three enzymes, a triphosphatase, a guanyl trans-
ferase, and a methyl transferase, all act in concert to add a cap to the 5’ terminus of the
primary transcript [Shuman, 2001]. The first two activities are present on a single polypep-
tide in mammals which gets recruited to the RNAP II initiation complex once the CTD has
become activated by Ser5 phosphorylation. Through direct association with CTD Ser5P,
the capping enzyme acts on nascent transcripts as soon as they emerge from the elongat-
ing RNAP II. Capping may well be a key component of the switch that pushes RNAP II
from abortive early elongation into fully processive elongation across the body of the gene.
Furthermore the 5’ cap allows the mature mRNA to circularize, thereby confering stability
and protecting from degradation [Rasmussen and Lis, 1993].
Transcript Splicing
In eukaryotes most pre-mRNA is composed of protein-encoding exons and large noncoding
intervening sequences, or introns. In the splicing process introns are removed and exons
are joined together to form the mature mRNA, used in translation to produce the correct
protein. Selective inclusion of different coding sequences (alternative splicing) results in the
production of different protein isoforms. For many eukaryotic introns, with exception of
self-splicing introns, splicing is catalyzed by the spliceosome. It consists of the U1, U2, U4,
U5 and U6 small nuclear RNPs (snRNPs) in conjunction with a large number of additional
proteins (reviewed in Stark and Lu¨hrmann [2006]). A series of RNA–RNA, RNA–protein,
and protein–protein interactions within the spliceosome is needed to remove intronic regions
and subsequently join exons, producing a mature transcript (reviewed in Collins and Guthrie
[2000]). Intron identification relies on specific sequences defining the 5’ and 3’ splice site.
In mammals, many genes contain multiple introns that are up to hundreds of thousands
of nucleotides in length [Waterston et al., 2002]. The presence of potential splice sites in
eukaryotes is not necessarily leading to selection of these sites by the spliceosome. Trans-
acting regulatory factors bound by pre-mRNA regulatory elements enhance or repress the
recruitment of snRNP to splice sites. These multiple factors together determine the actual
splice site in vivo. In mouse more than 50% of the transcripts are subject to alternative
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splicing, represents an important source of flexibility in gene expression.
As part of the large splicing complex, there are a number of proteins, which leave a mark
on spliced mRNAs and thereby direct localization, translation and decay of the mature
mRNA. The most studied eukaryotic splice-dependent mark is the exon junction complex
(EJC). EJCs are stably deposited ∼20 nucleotides upstream of exon-exon junctions [Le Hir
et al., 2000]. They play a role in non-sense mediated decay (NMD) and directly enhance
translation initiation by promoting the pioneer round of translation [Moore and Proudfoot,
2009]. In addition the THO/TREX complex associates with spliced mRNAs at the 5’-most
exon and promotes rapid export to the cytoplasm [Valencia et al., 2008]. Finally, a number
of DEAD-box proteins have recently been found to associate with mRNAs in a splice-
dependent manner. These proteins seem to influence many aspects of mRNA metabolism
[Rosner and Rinkevich, 2007]. All these evidences show that spliced mRNAs carry numerous
protein marks related to their splicing history, which has important downstream effects.
3’ End Processing: PolyA Addition
PolyA addition, or polyadenylation, occurs during the completion of the transcriptional pro-
cess, following transcription of the poly(A) site and cleavage of the transcript. 3’ cleavage
and polyadenylation of pre-mRNA are dictated by polyA signals that define the end of
the mRNA. These signals are recognized by a substantial cleavage/polyadenylation protein
complex (polyA complex) that is recruited to the Serine 2 phosphorylated form (Ser2P) of
the CTD through direct CTD-interacting domains (CIDs) as well as RNA binding domains
(RBDs) that specifically recognize the pre-mRNA polyA signals. Specific CIDs and RBDs
have been identified on individual polyA complex subunits [Proudfoot, 2004].
Polyadenylation, the final stage in pre-mRNA cotranscriptional processing, is a critical con-
trol point in preventing aberrant gene expression. When 3’ processing is either inefficient
or compromised by gene mutation, the nuclear exosome is recruited to rapidly degrade the
unwanted transcript. Finally, polyadenylation facilitates mRNA release from the transcrip-
tion site and its ultimate export through the nuclear pore complex (NPC) to cytoplasmic
translation. Like the 5’-cap structure, the 3’-polyA tail is important for mRNA stability in
the cytoplasm.
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2.2.2 Export of mRNA into the cytoplasm
Before an mRNA is exported into the cytoplasm it has to pass several mRNA quality control
steps. Splicing defective mRNAs as well as transcripts with aberrant 3’-ends are retained
at the site of transcription and directly degraded by the exosome in the nucleus. Once an
mRNA has passed the nuclear surveillance system, mRNA export factors, which have been
deposited on the mRNA during processing, interact with nuclear pore proteins and mediate
the transport of the mature mRNA into the cytoplasm [Hocine et al., 2010].
In mammals only about 5% of the total mass of RNA synthesized ever leaves the nucleus. In
section 2.2.1 the extensive mRNA processing, including splicing, capping, polyadenylation
and quality control was discussed. A large fraction of the transcripts that does not pass
these steps or is otherwise damaged, is immedately degraded. The export of the mature
mRNA transcript is delayed until all processing has been completed.
One of the few well described examples of regulated nuclear export that of the human im-
munodeficiency virus (HIV). The viral RNA directs the formation of double stranded DNA
and its insertion into the host genome, where it gets transcribed by the host cell’s RNAP
II. In order to produce progeny virus complete unspliced, intron containing, transcripts need
to be exported to the cytoplasm to be packaged into newly synthesized viral capsids. To
overcome the host cell’s normal block to export unspliced mRNA, HIV encodes a protein
REV, which, once translated, binds to the pre-mRNA of the virus in the nucleus and shuttles
it though the nuclear pore by interacting with the export receptor exportin 1.
A key mediator of nuclear mRNA export is the THO/TREX complex, mentioned in section
2.2.1. Consisting of the pentameric THO complex, which functions in transcription elon-
gation, and the mRNA export factors REF/Aly and UAP56, it associates with the 5’-most
exon of spliced mRNAs. UAP56 functions in spliceosome assembly [Iglesias and Stutz,
2008; Ko¨hler and Hurt, 2007], while REF/Aly bridges the mRNA to the export receptor
NXF1/ TAP. In mammals, REF/Aly and UAP56 appear to be recruited as a consequence of
splicing: when uncoupled from transcription in vitro, THO/TREX complex recruitment is
strongly 5’ cap and splicing dependent [Cheng et al., 2006; Masuda et al., 2005]. REF/Aly
binding can potentially increase the speed and efficiency of the export process [Valencia
et al., 2008] but is not essential for export in metazoans [Gatfield and Izaurralde, 2002].
In addition is was proposed that the positioning of the THO/TREX complex at the 5’-end
of spliced mRNAs influences direction of export, so that mRNAs exit the nuclear pore with
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the 5’-end first to directly become engaged in translation [Valencia et al., 2008]. In addi-
tion to the THO/TREX complex, serine/arginine-rich (SR) and SR-like proteins can also
function as mRNA export adaptors [Huang and Steitz, 2005]. These proteins are initially
recruited to pre-mRNAs for splicing in a hyperphosphorylated state, and become partially
dephosphorylated during the splicing reaction. Thus, it has been suggested that the ex-
port competence of the spliced messenger ribonucleoproteins (mRNP) is signaled by the
phosphorylation status of the bound SR proteins [Huang and Steitz, 2005].
2.2.3 Determinants of mRNA half-life
In procaryotes the rapid synthesis and degradation of mRNA is essential for their capacity
to adapt quickly to the environment. Transcripts in bacteria like E.coli live in the cytoplasm
on average less then 5 minutes [Bernstein et al., 2004]. In eukaryotes, the dynamic range
of transcript half-life is much bigger: housekeeping transcripts, from the β-globin gene for
example, can be present for more than 10 hrs [Sharova et al., 2009] while TF-mRNAs are
degraded relatively fast [Yang et al., 2003].
As described in section 2.2.1 most mRNAs acquire a 5’ cap structure and a 3’ polyA tail
during co-transcriptional processing in the nucleus. A so called cap-binding complex induces
the circularization of the transcript, which both, facilitates translation and protects it from
degradation.
There are two general ways a transcript can be degraded: from the 3’ or from the 5’ end.
From the 3’ end the polyA tail gets shortened as soon as the transcript is exported to the
cytoplasm. PolyA shortening is like a timer that counts down lifetime. When the polyA
tail reaches a critical length, in mammals ∼25 nt, two pathways of degradation diverge:
(I) Either exonucleases continue to shorten the transcript from the 3’ end into the coding
region or (II) the 5’ cap is removed (decapping) and the exposed mRNA is rapidly degraded
from the 5’ end by the exonuclease Xrn1. Most eukaryotic RNA is actually degraded by
both mechanism.
Usually, specific sequence properties of each transcript determine how fast the degradation
occurs and thereby how long the mRNA is available in the cytoplasm to be subject to trans-
lation into protein. Especially 3’ un-translated region (UTR) sequences often carry binding
sites for proteins, which specifically enhance or slow down the rate of polyA shortening,
decapping or 3’-5’ degradation. At the same time translation itself regulates the stability of
the respective mRNA: if ribosome and translation machinery are bound, degrading enzymes
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are less likely to access and act on this transcript. (reviewed in Parker and Song [2004])
Apart from the two general ways of degradation there are cases where specific nucleases
cleave the mRNA internally, which leads to rapid degradation. Transcripts which are de-
graded in this way, usually carry specific sequences in their 3’ UTR, which serve as recog-
nition sites for endonucleases to bind.
Sequence-specific mRNA repression
Post-transcriptional regulation is mediated by RBPs or small RNAs, so called, trans-acting
factors, which bind to specific cis elements in UTRs of an mRNA. This binding can then
influence mRNA degradation, sequestration, localization and translation. Most regulatory
sequences bound by trans-acting factors, are located within the 3’ UTR of an mRNA [Mer-
ritt et al., 2008; Stark et al., 2005].
Trans-acting factors and cis-acting elements
Although the 3’ UTR in a long linear RNA molecule is quite distant from the cap, the
closed loop structure, discussed above, brings both of these features into close proximity
and thereby allows the 3’ UTR to impact on translation initiation. Numerous cis elements
located in the the 3’ UTR have been described, however, only few reports, find regulatory
sequences in the 5’ UTR. For instance AU rich element (ARE) are found in mRNAs encod-
ing for cytokines, interleukins and proto-oncogenes [Caput et al., 1986; Shaw and Kamen,
1986]. Several ARE binding proteins (ARE-BPs) have been identified, which tightly regu-
late the turnover of transcripts they bind to: While the CCCH tandem zing-finger protein
tristetraprolin (TTP) promotes mRNA degradation [Lykke-Andersen and Wagner, 2005],
the ELAV protein family member HuR, another ARE-BP, has a stabilizing effect on its
target transcript [Fan and Steitz, 1998].
Proteins that bind to 3’ UTR elements can influence the stability of the transcript in sev-
eral ways. They can regulate mRNA transport within the cytoplasm or assemble repressive
complexes which sequester the mRNA away from the translation machinery. Moreover,
trans-acting factors may recruit mRNA decay enzymes, thereby inducing degradation. Be-
sides RBPs, another group of important trans-acting factors are small regulatory RNAs, like
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piRNAs and miRNAs.
In the following section I will describe miRNAs in more detail as they will be the most
relevant trans-acting factor for my PhD thesis.
2.2.4 Transcript decay by MicroRNAs
miRNAs were first discovered in 2001 in C.elegans [Lagos-Quintana et al., 2001; Lau et al.,
2001; Lee and Ambros, 2001]. Since then, this species of small RNA became recognized
as key regulators in gene expression, influencing a wide range of biological processes, post-
transcriptionally, including cell proliferation, differentiation, metabolism and development
(reviewed in Krol et al. [2010]).
Like mRNAs, miRNAs are initially transcribed by RNAP II in the nucleus, where they form
pri-miRNA precursors, folded into a so called ’hairpin’ structure. These precursors are pro-
cessed by the endoribonuclease Drosha, yielding shorter ’hairipins’, termed pre-miRNAs,
which are subsequently exported to the cytoplasm by the export factor exportin 5. In the
cytoplasm a second processing enzyme, Dicer, cuts the loop of the folded pre-miRNA and
leaves a 22nt long double-stranded RNA. From this double-strand one, the mature miR-
NAs, is incorporated together with several RNA binding proteins into the miRNA induced
silencing complex (miRISC). The miRISC locates its targets via basepairing between the
loaded miRNA and the target 3’ UTR and thereby represses mRNA expression. Key com-
ponents of the miRISC, and crucial for target mRNA repression are the Argonaute and
GW182 proteins, which interact with other proteins to affect translation initiation or recruit
mRNA decay enzymes (reviewed in Krol et al. [2010]). Initially, it was believed that in
animals miRNAs would affect gene expression mainly via translation inhibition, because the
complementary region between the miRNA and its target mRNA is very short (6-8 nt), in
contrast to the almost full complementarity in plants [Llave et al., 2002; Rhoades et al.,
2002]. While a lot of progress was made understanding the biogenesis and function of
miRNAs the actual mechanism that miRNAs use to regulate gene expression is subject to
a controversy (reviewed in Huntzinger and Izaurralde [2011]). There are in principle two
different views: (I) miRNAs function on the level of actual mRNA degradation or (II) they
only inhibit translation of the target but leave the transcript intact (Figure 2.5). The latter
mechanism, translational repression, has been suggested to occur in four different ways: in-
hibition of translation initiation, inhibition of translation elongation, premature termination
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of translation, and co-translational protein degradation.
The first studies on miRNA-mediated repression mechanism in C.elegans suggested that
Figure 2.5: Proposed models of miRNA mediated gene expression silencing. A miRNA might act on
different stages of gene expression: it might prevent transcription initiation or elongation or act to
degrade the target mRNA by deadenylation and subsequent decay mechanisms.
the repression happens post-initiation, because protein expression of target mRNAs was
inhibited while RNA could still be detected on polysomes [Maroney et al., 2006; Olsen and
Ambros, 1999; Seggerson et al., 2002]. This could be either because ribosomes drop off
from the transcript prematurely [Petersen et al., 2006] or because proteins are degraded
co-translationally [Nottrott et al., 2006].
Contrasting studies showed the absence of miRNA targets from the polysomal fraction [Pil-
lai et al., 2005] and concluded that translation is repressed already at the initiation step.
This theory was supported by the observation that miRNA mediated silencing could be
avoided if translation was driven by an internal ribosome entry site (IRES) [Iwasaki et al.,
2009; Mathonnet et al., 2007]. The transcription initiation complex eIF4F, which binds
polyA tail and cap, was actually observed to be affected because adding purified eIF4F
continuously abrogated silencing [Ding and Grosshans, 2009].
This last finding may not be in conflict with the option that miRNA target supression acts
on the level of transcript degradation. Because of the imperfect pairing of the miRNA with
its target endonucleolytic cleavage it is unlikely, however the miRNA can direct its target to
the cellular 5’-3’ miRNA decay pathway, where the circular conformation of the transcript is
broken up and progressive deandenylation takes place. The degradation theory is supported
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by numerous evidences from specific miRNA-target pairs as well as transcriptome studies.
The depletion of a miRNA lead to increased abundance of mRNAs with complementary
target sites [Baek et al., 2008; Kru¨tzfeldt et al., 2005] and conversely, the introduction of
a miRNA into the cell resulted in decreased levels of potential targets [Baek et al., 2008;
Guo et al., 2010; Hendrickson et al., 2009; Lim et al., 2005]. In addition the depletion of
any essential proteins of the miRNA biogenesis pathway had the same effect as deleting
mature miRNAs: target mRNAs accumulated [Behm-Ansmant et al., 2006; Eulalio et al.,
2009, 2007; Giraldez et al., 2006; Rehwinkel et al., 2005]. Without interfering with a cell,
expression profiles of differentiating cells show anticorrelation of miRNA expression and tar-
get [Farh et al., 2005; Stark et al., 2005].
Studies employing quantitative mass spectrometry agreed that miRNAs have only a minor
effect on protein level [Baek et al., 2008; Selbach et al., 2008]. Two more recent papers,
which use translation profiling by monitoring polysome bound mRNA estimate that mRNA
degradation explains 75-84% of miRNA-mediated changes in protein level [Guo et al., 2010;
Hendrickson et al., 2009]. In summary, evidence for rapid mRNA degradation as the main
mechanism of miRNA mediated regulation accumulates, which means that the effect of
a miRNA on its targets should be measured on the level of mRNA abundance. This as-
sumption will be important in the second part of my PhD project, when investigating the
contribution of miRNAs to steady state mRNA level.
2.2.5 Readout of post-transcriptional events: mRNA half-life
After the mRNA gets transcribed and exported to the cytoplasm, the process of RNA
degradation begins immediately. How fast a transcript is degraded is different for every
mRNA as described in the previous sections. Depending on RNA sequence but also on the
expression of interacting proteins a transcript will have a certain half-life, the time after
which only half of the initial transcript will be existent in the cell. Transcript decay or
degradation λ is indirectly proportional to half-life t1/2,
t1/2 =
ln(2)
λ
,
assuming an exponential decay process. Measuring abundance of a transcript at a time
point t reflects the equilibrium between transcript synthesis and decay. To monitor only
RNA decay, we therefore have to mask the synthesis process from our measurement. This
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can be done in different ways:
The direct, however strongly invasive, method is to stop transcription in the cell. This can
be done by arresting RNAP II by various chemicals, such as α-amanitin or actinomycin-D.
From the moment of transcription arrest, no new transcript is being synthesized and one
can measure the decrease of mRNA per gene over time. Typically, this time-course is not
longer than a couple of hours because the RNAP II arresting chemicals also interfere with
other cellular processes and may alter the speed of degradation [Do¨lken et al., 2008]. For
fast dividing cells, such as ESC in our experiments, we even observe cell death after 8 hrs of
actinomycin-D treatment. Nevertheless, this method has been widely used in genome-wide
studies as it allows for a global quantification of the decaying mRNA pool by either microar-
ray or RNA sequencing. Isolating RNA at each time point after transcription arrest from the
exact same number of cells, results in a decreasing amount of total RNA obtained over time.
This is precisely what we would like to monitor, however, both microarrays and sequencing
technology require to use a specific amount of starting material (in this case RNA) for every
experiment, which at time point t0 can be obtained from half the amount of cells compared
to t1/2, where on average half of the mRNA is degraded. This can be solved by either ’filling
up’ the required RNA amounts by an artificial spike-in RNA or we can make use of the fact,
that most of the RNA in a cell (> 80%) actually comprises ribosomal RNA, which is known
to have a long half-life (∼ 5 days, Loeb et al. [1965]). In addition rRNA is transcribed
by RNAP I, which is not inhibited by actinomycin-D. Consequently, we will not see rRNA
decreasing during the time-course experiment of a few hours, however, the relative amount
of mRNA in the RNA pool will decrease. Importantly, resulting microarray intensities from
these experiments must not be normalized between arrays, as this would erase the signal of
global mRNA decrease. For each transcript monitored on the array, one can infer a linear
fit from the log transformed signal intensity depending on the time after transcription ar-
rest. The slope of the regression line corresponds to the decay λ in the equation above and
by plugging in the time interval of the experiment, one can obtain the half-life t1/2 in hours.
Due to the side-effects of the transcription arrest, a less invasive, method has become state
of the art measuring mRNA decay rates during the last years: metabolic labeling [Do¨lken
et al., 2008; Rabani et al., 2011]. Here a ’label’, for example a modified nucleotide, is
added to the cell in excess for a certain time period, in which all mRNA synthesized will
incorporate this label. One can then specifically separate labeled (newly synthesized) and
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unlabeled (pre-existing) mRNA. With time the fraction of the labeled over unlabeled RNA
increases until all pre-existing RNA is degraded and all mRNA is labeled. Quantitative mea-
surement (microarray or RNA sequencing) is done between start of labeling and complete
labeling for all three fractions: labeled, unlabeled and total RNA separately. Importantly, it
is sufficient to do this measurement at one time point, because we know that at timepoint
t0 (before labeling) the ratio of
unlabeled
total = 1. To calculate decay rates from the ratios
obtained at this time point t0+x use:
T1/2 = −t ∗
ln(2)
ln(1− 1
1+
(labeled/total)
(unlabeled/total)
)
,
again assuming exponential decay. Although, the advantage of this method is that the incor-
poration of a labeled nucleotide does not interfere with expression levels, a major downside
is the IP based separation of labeled and unlabeled RNA. Depending on the labeling time
this will enrich for a very small fraction of transcripts and is potentially subject to sequence
biases. Further necessary purification steps add more potential steps for introduction of
systematic errors. One has to be cautious when processing metabolic labeling data: The IP
enriches for biotinylated labeled uridines (thio-U), the U frequency within a transcript will
influence the enrichment, a newly transcribed mRNA with many Us will be more enriched
than one with low U frequency even if both have been similarly transcribed. Therefore
a U-normalization step is required before plugging in the labeledtotal fraction into the above
formula.
Both methods measuring mRNA half-life have their individual shortcomings but unless
one would have a reference of the ’real’ mRNA half-life of each transcript it can not be
decided which method is superior. A report which measures mRNA half-lives in parallel
using both methods in the same system, shows a very low correlation meaning either one or
both methods do not reflect actual decay rates. Assuming these experimental limitations,
one has to take interpretations of mRNA half-life with a grain of salt, however, in theory
the decay rate of a transcript should reflect its entire history from the moment it was tran-
scribed, processed, exported and subject to decay or miRNA mediated silencing.
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2.3 Introduction to the Theoretic Approach
The above two introductory sections were concerned with biological aspects that build the
basis for my PhD Thesis. While this biological background is sufficient to raise the question
of the thesis, a basic introduction to statistical methods, that I will use, is necessary to
formulate the problem. In this section I will briefly introduce regression analysis with regard
to the biological background of my PhD topic. This will help me to formulate the scope of
my thesis in the following section 2.4.
2.3.1 Regression Analysis
Regression type problems were first considered in the 18th century to aid navigation. The
method was almost exclusively used in physical sciences until later in the 19th century,
where Francis Galton established the term ’regression to mediocracy’ in 1875 and intro-
duced r as the correlation between two variables x and y [Galton, 1890].
Galton used this definitions to explain a phenomenon called ’regression effect’: the obser-
vation that sons of tall fathers tend to be tall but not as tall as their fathers and sons of
short fathers tend to be short but not as short as their fathers. His work was later extended
by Karl Pearson to a more general statistical context [Magnello, 1998]. In the 1950s and
1960s, economists used electromechanical desk calculators to calculate regressions and be-
fore 1970, it took up to 24 hours to receive the result from one regression. With the advent
of high-speed computing regression methodology developed rapidly and as computing hard-
ware improved the scope for this analysis has widened.
Simple Regression
In sections 2.1 and 2.2 I introduced transcriptional and post-transcriptional processes in
the cell that play a role in gene expression regulation. Suppose we wish to forecast the
abundance of a certain transcript in a cell, we now have plenty of information which factors
are associated with variations in mRNA levels, chromatin, transcription, export, processing,
degradation etc. For the time being let us restrict to one factor: call it RNA polymerase
II occupancy at the promoter of the gene. Regression analysis with a single explanatory
variable is termed simple regression.
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We assume, possibly quite unrealistically, that mRNA level can be measured by a single
attribute — RNA Polymerase II occupancy (RNAP). Initially in any regression study, one
formulates a hypothesis about the relationship between the variables of interest, here, RNAP
and mRNA level, based on, for example, mechanistic knowledge in the process of transcrip-
tion. Thus, the tentative hypothesis is that higher levels of RNAP cause higher levels of
mRNA, other things being equal. To investigate this we collect data from a number of
genes in the genome, by RNA-sequencing and RNAP II-ChIP-seq. Because we have prior
knowledge about the generation of the sequencing data, we know that it has to be logarith-
mically transformed before testing our hypothesis. We can now plot this information for all
genes using a two-dimensional scatter plot, where each point represents one gene. The plot
suggests that more RNAP indeed yields higher mRNA levels but at the same time the the
relationship is not perfect. Regression analysis embraces the idea that other factors than
RNAP influence mRNA levels. Thus the new hypothesis is that the mRNA level for each
gene is determined by RNAP and an aggregation of omitted factors that we term ’noise’.
The relationship can be written:
mRNAi = α+ βRNAPi + ,
where α is a constant, β the effect or ’coefficient’ of RNAP, hypothesized to be positive and
 the ’noise’ term reflecting other factors that influence mRNA level. The variable mRNAi
called the dependent variable or response and RNAPi is the independent or explanatory
variable or predictor. Note that the relationship between mRNA and RNAP is the equation
for a line with an intercept α and a slope β. Regression estimates the line, which minimized
the sum of squared errors (SSE), with error being the vertical distance of each gene from
the regression line.
Multiple Regression
Plainly, mRNA levels, as described in previous section are affected by a variety of factors
in addition to RNA polymerase occupancy, factors that were aggregated into the ’noise’
term in the simple regression model above. Multiple regression allows additional factors
(predictors) to enter the analysis separately so that the effect of each can be estimated.
It is valuable for quantifying the impact of various simultaneous influences upon a single
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response variable. For example histone marks are connected with transcription and may be
incorporated in the regression. The modified model may be written:
mRNAi = α+ βRNAPi + γH3K36 + i,
The task of estimating the parameters α, β, and γ is conceptually identical to the earlier
task, in contrast we can no longer think of regression as choosing a line in a two-dimensional
diagram. With two explanatory variables we need three dimensions, and instead of esti-
mating a line we are estimating a plane. Multiple regression analysis is capable of dealing
with an arbitrarily large number of explanatory variables, e.g. more histone modification
measures may be included.
Another common statistic associated with regression analysis is the R2, which will be used
as an estimator of goodness of the model throughout the thesis. R2 has a simple definition:
it is equal to one minus the ratio of the sum of squared estimated errors (the deviation of
the actual value of the dependent variable from the regression line, SSEfit) to the sum of
squared deviations about the mean of the dependent variable (SSEmean).
R2 = 1− SSEfit
SSEmean
The R2 statistic necessarily takes on a value between zero and one. A high value of R2,
suggesting that the regression model explains the variation in the dependent variable well,
is obviously important if one wishes to use the model for predictive or forecasting purposes.
The SSE about the regression line is a measure of the extent to which the regression fails to
explain the response variable. Hence, the R2 statistic is a measure of the extent to which
the total variation of the response variable is explained by the regression.
Non-Linear Regression
In statistics, nonlinear regression is a form of regression analysis in which observational
data are modeled by a function which is a non-linear combination of the model parameters
and depends on one or more independent variables. The data are fitted by a method of
successive approximations. In contrast to linear regression we can not estimate the optimal
’true’ coefficients for each predictor. In non-linear regression the parameter fitting is an
iterative ’try and error’ process which terminates upon a stop criterion, for example if the
SSE is below a certain threshold. In some cases where the relationship between the predictor
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and the response variable is not linear but can be defined by another relation (exponential,
logarithmic, trigonometric, power function...) one or both variables can be transformed to
yield linear relation and use linear regression with the transformed variables. However, if
the relation between the variables is more complex, one can employ non-linear regression.
This way one might be able to catch plateau effects in biological measurements or other
biases which are known to be technical. One should use non-linear modeling with caution
because non-linear relationships between variables are much harder to interpret and it may
be more useful to understand a biological process having a linear model with a higher SSE
that is interpretable than a non-linear model, where the relationship between predictors is
not clear.
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2.4 Motivation, Idea and Scope of Thesis
“The formulation of the problem is often more essential than its solution which may be
merely a matter of mathematical or experimental skill.” [Albert Einstein]
All different cell types in a multicellular organism arise from one fertilized cell. During repli-
cation and differentiation the genetic information is static while differentiated cells show an
enormous diversity in phenotype and function. This results from varying expression patterns
of the genes in an organism’s genome and the resulting protein pool in each cell, which is
determined by the cell’s gene regulation system.
Gene regulation is a multilayered process, which starts in the nucleus of the cell and con-
tinues in the cytoplasm (Figure 2.6). To regulate which gene is expressed at which time
involves a complex interplay between proteins (transcription factors) that bind DNA in a
sequence-specific manner as a genetic component, and the epigenetic state of the target
sequence, defined at large by modifications of DNA and bound histones. In addition to this
RNA synthesis determining steps, RNA degradation plays a role in setting up which tran-
scripts will be available to the ribosome for translation. RNA binding proteins and particular
small non-coding RNAs are well studies molecules mediating such post-transcriptional reg-
ulation.
When I started my PhD in 2008, genome-wide mapping of histone modifications switched
from ChIP-chip technology to ChIP followed by deep-sequencing (ChIP-seq). The first high-
resolution maps in mammals derived by ChIP-seq [Barski et al., 2007; Mikkelsen et al., 2007]
together with deep sequencing studies of corresponding transcriptomes [Mortazavi et al.,
2008; Wang et al., 2009] allowed to correlate mRNA expression with the epigenetic state
of a certain cell type. This revealed a genome-wide contribution of active and repressive
histone marks at promoter regions with transcription. At the same time the flood of new
RNA sequencing data [Affymetrix ENCODE Transcriptome Project and Cold Spring Harbor
Laboratory ENCODE Transcriptome Project, 2009] allowed detection of a large pool of RNA
molecules previously masked by targeted microarray approaches and supported theories of
pervasive transcription [Carninci et al., 2005; Pheasant, 2007; Taft et al., 2006] outside
of protein coding-genes [Carninci, 2009; Core et al., 2008; Seila et al., 2008; Wang et al.,
2009]. While both, epigenetic modifications of chromatin as well as regulatory RNAs, were
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Figure 2.6: This sketch illustrates a simplified view of locally separated regulatory processes of RNA
expression in an eukaryotic cell. Histone modifications, chromatin and transcription in the nucleus and
different mechanisms of RNA degradation in the cytoplasm.
reported to be linked to mRNA expression and different phenotypes, there was no study
comparing the contribution of these regulatory layers on a quantitative base.
To meet this challenge we made use of an in vitro differentiation system of ESC to terminal
neurons [Bibel et al., 2007], where chromatin modification maps and transcription data was
readily available from previous studies in the lab [Lienert et al., 2011; Mohn et al., 2008;
Tiwari et al., 2012]. With this and public data in the same cell type [Mikkelsen et al., 2007]
we initially identified the chromatin readouts most relevant for mRNA levels. We found
that together with RNAP II occupancy and two other histone modification at the promoter
region (H3K4me2 and H3K27me3), H3K36me3, a co-transcriptional histone mark, is most
predictive for mRNA abundance. Hence, we generated high-resolution H3K36me3 maps by
ChIP-sequencing in our in vitro differentiation system and used a regression model to inte-
grate these maps with the other available ChIP-seq data in order to predict transcription.
The idea of our study, is that given these chromatin-based transcription measures, it would
be impossible to capture information from the post-transcriptional layer. Therefore any de-
viation between the chromatin-derived ’predicted transcription’ and actual measured mRNA
levels should be due to regulation that happens after the RNA is synthesized, meaning post-
transcriptionally. In order to quantify the relative contributions of these layers of regulation
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we primarily infer the explained variance of mRNA levels by the linear combination of histone
marks and RNAP II occupancy and secondly, determine how much of the remaining variance
might be explained by post-transcriptional processes. We aimed to quantify this effect of
post-transcriptional regulation by measuring mRNA decay rates initially by transcription ar-
rest in our system. Later we compared these results with metabolic labeling of RNA, which
emerged as the method of choice to defined decay rates [Do¨lken et al., 2008]. Specifically,
we wanted to describe the quantitative contribution of miRNAs to post-transcriptional de-
cay of their respective target transcripts. To this end we inferred abundance of small RNAs
throughout in vitro differentiation in our system by small RNA sequencing. We integrate
the miRNA abundance with experimentally [Sinkkonen et al., 2008] and computationally
predicted miRNA-target interactions [Gaidatzis et al., 2007] with the data derived on the
chromatin level and compare their relative contributions to steady-state mRNA level as well
as changes in mRNA abundance throughout differentiation.
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Abstract
Messenger RNA levels in eukaryotes are controlled by multiple consecutive regu-
latory processes, which can be classified into two layers: Primary transcriptional
regulation at the levels of chromatin and secondary, co- and post-transcriptional
regulation of the mRNA. To identify the individual contribution of these layers to
steady-state RNA levels requires separate quantification. Using mouse as a model
organism, we show that chromatin features are sufficient to model RNA levels
but with different sensitivities in dividing versus post-mitotic cells. In both cases
chromatin derived transcription rates explain over 80% of the observed variance in
measured RNA levels. Further inclusion of measurements of mRNA half-life and
microRNA expression data enabled the identification of a low quantitative contri-
bution of RNA decay by either microRNA or general differential turnover to final
mRNA levels. Together this establishes a chromatin based quantitative model for
the contribution of transcriptional and posttranscriptional processes to steady-state
levels of messenger RNA.
3.1.1 Introduction
Regulation of mRNA levels is a key mech-
anism that defines cell identity. Cellular
homeostasis requires stable gene expres-
sion patterns, while differentiation events in
metazoan development or responses to ex-
ternal stimuli involve resetting of the tran-
scriptional program. During the lifespan of
an mRNA from transcription over matura-
tion, export, translation and decay, its ac-
tivity and abundance is controlled by vari-
ous mechanisms: histone modifications and
DNA methylation determine the epigenetic
state of the chromatin environment of a
gene depending on the DNA accessibility
the transcription machinery can bind and
initiate transcription and thereby produce
primary transcript at different rates [Bell
et al., 2010; Segal and Widom, 2009]. This
is modulated co-transcriptionally by splic-
ing and poly-adenylation [Di Giammartino
et al., 2011; Millevoi and Vagner, 2010;
Nilsen and Graveley, 2010] and further reg-
ulated at the level of nuclear export. Once
the mRNA is in the cytoplasm it is sub-
ject to further post-transcriptional process-
ing, that can reduce the transcript level
in a targeted manner. Two major post-
transcriptional regulatory processes influ-
encing the amount of mRNA molecules
available for translation are general RNA
decay and microRNA-mediated RNA inter-
ference. Single-gene experiments have pro-
vided examples of the involved regulatory
mechanisms that include transcription fac-
tor binding but also what is currently re-
ferred to as epigenetic regulation. These
summarize chromatin regulation of DNA
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accessibility through active or repressive
histone modifications [Kouzarides, 2007]
or nucleosomal positioning [Kornberg and
Lorch, 1999; Wyrick et al., 1999], transcrip-
tional repression by DNA methylation of
gene promoters [Bird, 2002; Eckhardt et al.,
2006; Weber et al., 2007] and post- tran-
scriptional regulation of RNA decay rates
by non-coding small RNAs [Ambros, 2004].
Additionally, genome-wide studies success-
fully approximated mRNA levels with infor-
mation of transcription factor binding and
histone modification patterns at promoter
proximal sequences [Cheng and Gerstein,
2011; Karlic et al., 2010; Ouyang et al.,
2009]. mRNA abundance however, may
be determined to different degrees by tran-
scriptional and post-transcriptional events
and the contribution of these layers may
vary depending on how stable or how fast
the expression change needs to be. At a
quantitative level, there is only a limited un-
derstanding of the individual contributions
of these regulatory layers. To understand
these relations we abstract the many lay-
ers into two processes: primary regulation
of synthesis or transcription on the level of
chromatin and secondary, post- transcrip-
tional degradation of mRNA. We assume
that the change of mRNA level (dR/dt)
depends linearly on mRNA synthesis and
degradation,
dR
dt
= txj [DNA]− dj [RNAj ] (3.1)
where [RNAj] is the RNA concentration for
gene j, [DNA] is constant ([DNA] = 1),
txj is the transcription rate and dj is the
degradation rate of gene j. For simpli-
fication, we initially assume the degrada-
tion rate to be constant, meaning indepen-
dent of gene j. Therefore in steady state
where dR/dt = 0, the RNA concentration
of gene j is proportional to transcription
and degradation rates of gene j. Subse-
quently when we investigate the contribu-
tion of post-transcriptional regulation, we
allow dj to depend on gene j (see supple-
mental information section 1 for details).
Consequently, we can estimate the individ-
ual contribution of transcription and mRNA
degradation, or mRNA decay, by correlat-
ing them to mRNA levels respectively. Here
we explore quantitatively how a prediction
of transcription based on chromatin char-
acteristics relates to mRNA levels and how
such an approach can quantify changes in
mRNA abundance that occur during the
course of cellular differentiation. We ask if
pluripotent and differentiated cells differ in
their regulatory behaviors, potentially relat-
ing to differences in cell cycle and the abil-
ity to set and propagate epigenetic marks
or a different usage of posttranscriptional
processes. As a biological model we use
mouse stem cells that we differentiate into
a highly pure neuronal population through a
defined progenitor state [Bibel et al., 2007].
We focus our analysis on pluripotent embry-
onic stem cells (ES) and post-mitotic gluta-
matergic neurons (TN). In order to quanti-
tate the contribution of different regulatory
processes to observed mRNA levels, we cre-
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ated a linear model for each cell type based
on various measures from transcriptional
and post- transcriptional layers. In these
models, a measure that is a strong corre-
late of transcription is expected to be highly
predictive of mRNA levels. We found that
genome-wide measures of histone modifi-
cations and polymerase occupancy alone
– measures which stand for the transcrip-
tional layer of regulation - allowed accurate
prediction of mRNA levels and explained
most of the observed experimental variation
in steady-state mRNA levels. In addition we
measured transcript half-life and microRNA
abundance in these cells, representing the
post-transcriptional layer of regulation, and
identified only a minor contribution to the
determination of mRNA levels.
3.1.2 Results
Histone marks are predictive of tran-
scription rate
In order to separately quantify transcrip-
tional and post-transcriptional processes on
a genome-wide level, we estimated tran-
scription rates for individual genes. Tran-
scription rate is a function of multiple fac-
tors: transcription factors bind influenced
by the chromatin environment and concor-
dantly determine the rate of transcription.
We use chromatin correlates of transcrip-
tion as readout, which can be measured
genome-wide in a robust way by chromatin
immunoprecipitation followed by deep se-
quencing (ChIP- seq). We created genome-
wide maps for RNA polymerase II (Pol-II)
and tri- methylation of lysines 4, 27 [Lienert
et al., 2011; Tiwari et al., 2012] and 36
in histone H3 (H3K4me2, H3K27me3 and
H3K36me3) in both dividing and post-
mitotic cells (see materials and methods for
details) and investigated the distribution of
sequence reads along the gene body in ref-
erence to gene activity defined by mRNA
abundance of representative transcripts (see
supplemental information section 2 for de-
tails). Figure 3.1 summarizes average distri-
butions of these marks for non-overlapping
genes: Pol-II, H3K4me2 and H3K27me3
are located around the promoter of the gene
[Boyer et al., 2006; Guenther et al., 2007;
Mohn et al., 2008; Rahl et al., 2010; Young
et al., 2011] while H3K36me3 is distributed
over the gene body [Barski et al., 2007;
Bell et al., 2007; Mikkelsen et al., 2007;
Pokholok et al., 2005] steadily increasing
within the first 2 kilo bases downstream of
the transcription start site (TSS). Based
on these observations, which are in ac-
cordance with previously published models
[Bell et al., 2007; Edmunds et al., 2008;
Hon et al., 2009; Vakoc et al., 2006], we
selected the regions to quantify these marks
for individual genes. While most of the hi-
stone marks have a functional impact close
to the TSS, the abundance of H3K36me3
throughout the gene body is notably by
far the most informative measure for tran-
scription (Figure 3.2, supplemental infor-
mation section 3 for details), as could be
expected from its mechanistic link to tran-
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Figure 3.1: Using histone marks and RNA polymerase II to model mRNA levels. Metagene plot
showing the distribution of histone marks along the gene body of genes aligned at their TSS with low,
intermediate and high expression levels.
scription: H3K36me3 chromatin mark is
set by a complex that associates with the
active elongating RNA-polymerase-II [Joshi
and Struhl, 2005; Keogh et al., 2005; Kizer
et al., 2005; Krogan et al., 2003; Li et al.,
2003, 2002; Pokholok et al., 2005; Strahl
et al., 2002; Sun, 2005; Xiao et al., 2003;
Yuan et al., 2009].
Using these marks as regressors (Figure
3.2) we infer a linear model, where mRNA
measured by deep sequencing is the re-
sponse variable (combining poly-A RNA
and ribosomal-depleted RNA sequencing,
for details see materials and methods) (Fig-
ure 3.2). The coefficients assigned to each
of the regressors by the linear model reflect
their function as active or repressive histone
mark (sign of the coefficients) and their
contribution to explaining transcription
(absolute value of the coefficients). The
correlation (controlled by a 2-fold cross-
validation) between observed and predicted
mRNA abundance is 0.92. This means that
84.6% of the observed differences in mRNA
levels (variance) can be explained by this
model (Figure 3.2, black bar) – exclusively
based on measures from the transcriptional
layer.
The remaining 15.4as measurement noise.
While post-transcriptional effects could be
explained by a more sophisticated model
that includes additional experimental data
from the post-transcriptional layer (see be-
low), the technical and biological mea-
surement noise cannot be predicted and
thus defines an upper limit of prediction
accuracy. We went on to partition this
sum, by (A) estimating the noise, and
thereby the maximum variance which can
be explained by our regressors and (B) as-
signing relative contributions of two major
post-transcriptional processes – microRNA-
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Figure 3.2: Using histone marks and RNA polymerase II to model mRNA levels. Scatter plot of RNA
polymerase II (Pol-II, green) and three histone marks H3K36me3 (dark blue), H3K4me2 (light blue),
H3K27me3 (orange) versus mRNA levels on the vertical axis. The number of reads aligned to either
gene body (H3K36me3, mRNA) or at the TSS (H3K4me2, H3K27me3, Pol-II) is shown in logarithmic
scale. Predicted transcription rate combining the four measures in a linear model versus mRNA level.
Axes as in B. Bar plot showing the fraction of total variance in mRNA levels that is explained by each
single histone mark, Pol-II occupancy or a linear combination of them (black). The maximally ex-
plainable variance (grey) is limited by the amount of measurement noise (see supplemental information
section 4 for details).
mediated degradation and RNA decay - to
final mRNA levels.
Estimating the upper bound of ex-
plained variance in RNA levels
Fluctuations in biological systems limit the
explainable variance of mRNA through the
variability between biological replicates. In
order to determine how much of the remain-
ing unexplained variance is due to such bi-
ological variability and measurement noise
versus actual post- or co-transcriptional
processes, we estimated the maximum vari-
ance to be explained given the variabil-
ity in the data. In the linear model
noise originates from both measurements
of mRNA levels and measurements of chro-
matin marks. Since we use multiple regres-
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sor measurements that each have indepen-
dent noise, their individual noise adds up,
which in turn sets the limits of explainable
variance. To estimate its upper bound we
follow the theory of noise propagation to
calculate model noise based on replicates
of RNA-seq and ChIP-seq experiments (see
supplemental information section 4 for de-
tails). This approach sets the maximal ex-
plainable variance in mRNA levels to 91%
(Figure 3.2, light-grey bar). The variance in
RNA levels, which remains to be explained,
is therefore the difference between this max-
imal to be explained variance and the vari-
ance that is already explained by the linear
model using transcriptional information. In
the case of ESC this difference is 6.4%.
The effect of degradation on steady-
state mRNA level
Having estimated transcription rate and an
upper bound for explainable variance we
next explored the remaining 6.4% unex-
plained variance. We assumed that genes
with lower measured RNA level than pre-
dicted by the transcription measures are
degraded more rapidly than average due
to post-transcriptional down-regulation of
their transcript. To test this hypothesis
we inferred the RNA decay rates of genes
by measuring their abundance in a time-
course after inhibition of transcription with
actinomycin D (see methods and supple-
mental information section 5 for details).
Transcript abundance was determined in
replicates at 0, 1, 2, 4 and 8 hours after
inhibition of transcription, but not later in
order to reduce secondary effects due to
long chemical treatment. From the degra-
dation slope we calculate the RNA half-life
according to Sharova et al. [Sharova et al.,
2009], summarized in Figure 3.3 and Figure
3.4. The high correlation between biolog-
ical replicates allowed us to extrapolate
half-life times up to 20 hours and thus to
include genes with slower decay rates. In
accordance with a previous study in mouse
ES cells [Sharova et al., 2009] we observe
a mean half-life of around 8 hours with
a distribution tailed towards longer half-
lives (Figure 3.4). The extremely short-
lived RNAs mostly belong to the class of
non-polyadenylated genes, which are not
protected from degradation (supplemental
information section 5, supplemental figure
7). These genes are expected to show lower
mRNA levels compared to other genes with
the same predicted transcription rate. In-
deed, short-lived RNAs are deviating nega-
tively from the linear fit. This is particularly
visible in the shift in the boxplots in Fig-
ure 3.4 in the 40-100% transcription bins,
while there are hardly short lived genes in
the low- transcribed bins (supplemental in-
formation section 5, supplemental figure 8).
The degree to which the half-life explains
additional variance in mRNA levels can be
quantified by the correlation of the half-
life with the residual of the linear fit. This
correlation is 0.3; meaning of the 6.4%
unexplained variance of mRNA levels in
the transcriptional model, mRNA half-life
46
3.1 Submitted Manuscript
7
8
9
10
l
l
l
l
l
l
l
l
l
l
l
l
l
l
0 2 4 6 8
actD treatment [hrs]
lo
g2
(S
ign
al 
Int
en
sit
y)
refSeq Gene
l
l
Adck5
Hist1h2bb
0 5 10 15 20
Half−Life [hrs]
Figure 3.3: Effect of RNA half-life on mRNA levels. (A) Example genes (short-lived histone gene
Hist1h2bb (orange) and the stable gene Adck5 (purple)) illustrating the inference of mRNA half-lives
from expression data. Data points correspond to measured mRNA abundance at various time points
after inhibition of transcription (time zero). (B) Half-life distribution of RefSeq genes with estimated
mRNA decay rates. Half-lives of very stable genes were set to 21 hrs (the maximal inferable half-life
given the experimental setup). (see supplemental information section 5 for details)
explains 0.32 = 9% (supplemental informa-
tion section 5, supplemental figure 9). As
an alternative we can simply include the
half-life as an additional feature in the lin-
ear model and infer the correlation to the
measured mRNA levels again. Indeed the
explained variance increases from 84.6% to
86%. To test if this result is independent
from the experimental approach to measure
half-life we next employed metabolic label-
ing of mRNA [Do¨lken et al., 2008; Rabani
et al., 2011; Schwanha¨usser et al., 2011].
After a short pulse of a modified ribonu-
cleotide newly synthesized and pre-existing
mRNA fractions are separated to determine
their differential abundance in order to es-
timate a decay rate. This method has the
advantage of not interfering with the tran-
scriptional program, as does actinomycin
D, and thus is less likely to cause indirect
effects [Do¨lken et al., 2008]. However it is
limited to a single time point. With this dif-
ferent approach we obtained a highly similar
additional contribution of mRNA half-life to
overall mRNA levels (total explained vari-
ance 85.9%; see supplemental information
section 6 for details). Notably, the variance
in mRNA levels explained by transcript half-
life measures alone is between 11 and 12%,
for thioU and actinomycinD derived half-
lives respectively. This sets a theoretical
upper bound for the relative contribution
of transcript half-life to mRNA levels and
further supports the observation of a minor
contribution of mRNA half-life to steady-
state levels inferred by different methods.
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Figure 3.4: Effect of RNA half-life on mRNA levels. Genes are classified into five equal groups accord-
ing to predicted transcription rate (0-100%), and within each group measured mRNA levels are shown
as box-plots separately for genes with different mRNA half-life (color-coded). Within a transcription
group with a sufficient number of genes, short-lived genes show less measurable mRNA than long-lived
genes. In the two low transcription bins (0- 40%) mRNA levels are less well modeled and they are
depleted of short-lived mRNAs. (see Supplemental Figure 7 for illustration)
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Figure 3.5: Effect of targeting by microRNAs on mRNA levels. (A) Scatter plot of Dicer+/− versus
Dicer−/− ES cells inferred by microarray measurement [Sinkkonen et al., 2008]. Genes with increased
mRNA levels in Dicer−/− are enriched for putative microRNA targets (orange), while genes with de-
creased mRNA levels are possibly affected by secondary effects (purple). (B) Distribution of the log
fold-change (logFC) between Dicer−/− and Dicer+/−.
The effect of microRNAs on steady-
state mRNA level
Next we investigated whether we can at-
tribute part of the observed mRNA half-life
to the activity of microRNAs that target
selected messages for degradation. To de-
fine the percentage of variance in mRNA
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Figure 3.6: Effect of miRNAs on mRNA levels. Genes are classified into five equal groups accord-
ing to predicted transcription rate (0-100shown as box-plots separately for genes with different log
fold-change between Dicer−/− and Dicer+/− (color coded). Within the same transcription group,
putative microRNA target genes (orange) show insignificantly different mRNA levels as non-target
genes (pvalue=0.303).
level that can be explained by microRNA
mediated degradation requires the identifi-
cation of mRNAs that are regulatory tar-
gets of microRNAs. This can be attempted
by identifying mRNAs bound to proteins in-
volved in the RNAi pathway (such as Ago-
IP [Beitzinger et al., 2007; Chi et al., 2009;
Hafner et al., 2010; Landthaler et al., 2008]
or by calculating the enrichment for motifs
complementary to the microRNA within 3’-
untranslated regions (UTR) of mRNAs [van
Dongen et al., 2008] or by predicting targets
using a combination of sequence, struc-
ture and conservation of the microRNA
and its target mRNA site [Enright et al.,
2003; Gaidatzis et al., 2007; Krek et al.,
2005; Lewis et al., 2003; Rehmsmeier et al.,
2004]. These methods share a high false-
positive rate since actual targets are not
only defined by sequence complementarity
alone, but by additional sequence and struc-
tural constraints and other modulating fac-
tors that are currently only poorly under-
stood. In order to circumvent these poten-
tial limitations we initially based our defini-
tion of microRNA-targets on mRNAs that
increase in expression in ES cells that lack
microRNAs due to a genetic deletion of
the gene encoding Dicer [Hutva´gner et al.,
2001; Murchison et al., 2005]. An increased
mRNA abundance in Dicer−/− cells sug-
gests that these transcripts had been under
negative control by microRNAs in wild-type
ES cells (Figure 3.5). Consequently we cor-
relate fold-changes in mRNA abundance be-
tween Dicer+/− and Dicer−/− cells with
the deviation from the model in the linear
fit (also referred to as ‘residual of the linear
fit’). This did not reveal a relationship be-
tween negative residuals indicative for post-
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Figure 3.7: Focus on high-confidence microRNA target genes. (A) All RefSeq genes are classified into
three color-coded groups according to up-regulated in Dicer-/- (orange), down-regulated in Dicer−/−
(purple) and unchanged (grey). (B) Subset of all the genes in (A), where the absolute log fold-change
(logFC) between Dicer−/− and Dicer+/− is higher than 0.5. This subset contains likely targets and
non-targets. (C) Pearson correlation (r) between the residual of the linear model and the logFC between
Dicer−/− and Dicer+/− as a function of cut-off in absolute logFC between Dicer−/− and Dicer+/−.
A logFC cut-off of zero corresponds to (A), and a cut-off of 0.5 (solid vertical line) corresponds to
(B). Correlations are shown for subsets of genes for logFC cut-offs incremented in 0.1 intervals. The
point size illustrates the number of genes at each cut-off. At 0.8, the subset contains 1000 genes
(dashed line), the subset at 1.9 contains 100 genes (dotted line). Increasing logFC cut-offs select
higher-confidence microRNA-target genes that can explain the residual of the linear fit increasingly
better.
transcriptional regulation and the likelihood
of an mRNA being a microRNA target (cor-
relation between fold-change upon Dicer
KO and residual is r = 0.01; Figure 3.6, sup-
plemental information section 7). Impor-
tantly however, it has been shown that ex-
pression changes of mRNAs upon removal
of all microRNAs in Dicer−/− cells are rel-
atively small in general ( 2-fold) [Babiarz
et al., 2008]. It is thus conceivable that
such small effects are not detectable in the
population of all mRNAs that consist of
targets and non-targets, changing their ex-
pression both, through direct effects caused
by the lack of microRNAs and indirect ef-
fects unrelated to microRNAs. To test
this hypothesis we directly compared high-
confidence targets (based on fold-change in
abundance) with non- targets (Figure 3.7,
B). We stepwise increase the cut-off applied
50
3.1 Submitted Manuscript
to the change in mRNA levels upon Dicer
KO to define microRNA targets, thereby se-
lecting a smaller and smaller subgroup and
inferred for each of these subgroups the cor-
relation of residual and fold-change (Fig-
ure ??). In these groups of higher confi-
dence microRNA-targets, we can detect a
negative correlation with the residual (Fig-
ure ??, dotted line, supplemental informa-
tion section 7, supplemental figure 14). We
thus conclude that genes that are likely mi-
croRNA targets have indeed less detectable
transcript than expected based
Transcriptional and posttranscriptional
regulation in dividing versus post-
mitotic cells
Having established that chromatin and
bound polymerase are highly predictive of
mRNA levels in rapidly dividing stem cells
we next asked if the same trend is observed
in post-mitotic neurons that have exited
the cell cycle. Consequently we differen-
tiated stem cells first into neuronal pro-
genitors (NPs), which show reduced pro-
liferation and further into terminal neu-
rons, which do not divide. Similarly to
the analysis in ES we determined globally
the abundance of mRNA, microRNA, Pol-
II and of several histone marks and rebuild
the linear model. This revealed that at
all three stages chromatin data are com-
parably predictive for mRNA levels (Figure
3.8). To compare post-transcriptional con-
tribution between cell-types we also derived
mRNA half-life datasets at the TN stage.
Including mRNA half-life in TN as regres-
sor in the linear model increased explained
variance (r2) of mRNA in TN about 1%,
from 79% to 80%, revealing an equally low
contribution of mRNA degradation in neu-
rons as the one observed in dividing stem
cells. Together this suggests that there is no
general change in regulatory contributions
once stem cells have exited the cell cycle
and, in this particular case, gain neuronal
functions. Having defined the relation be-
tween chromatin measures, RNA decay and
mRNA abundance at individual cell states
we next asked whether changes in transcrip-
tion or changes in degradation between cell
states are equally predictive for changes in
mRNA levels. We fitted the linear model
using the differences in measurements be-
tween two cell types, which reveals that
changes in chromatin can indeed predict
67% of the change in mRNA levels. Sim-
ilarly changes in transcript half-life can ex-
plain 1% of the remaining variance (see sup-
plemental information section 9 for details).
This illustrates that the experimental mea-
surements in combination with the applied
analytical approach enable quantification of
the relative contributions of transcription
and degradation to changes in mRNA lev-
els.
Influence of cell division on the informa-
tion content of transcription- coupled
chromatin marks
H3K36me3 is set by a histone methyltrans-
ferase which interacts specifically with the
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Figure 3.8: H3K36me3 explains most of the variance in mRNA level. Scatter plot of predicted tran-
scription rate versus measured mRNA level for the ES, NP and TN. (B) Distribution of mRNA levels
in ES, categorized into low and high expression groups. (C) Correlation (r) between H3K36me3 and
mRNA for genes in expression groups from (B) in ES, NP and TN. The correlation of H3K36me3 with
mRNA level differs between dividing cells and post-mitotic TN cells: In diving cells (ES and NP), it is
best for high expressed genes, while in the post-mitotic TN, it is best for low expressed genes.
elongating RNA-polymerase-II [Joshi and
Struhl, 2005; Keogh et al., 2005; Kizer
et al., 2005; Krogan et al., 2003; Li et al.,
2003, 2002; Pokholok et al., 2005; Strahl
et al., 2002; Sun, 2005; Xiao et al., 2003;
Yuan et al., 2009]. As a consequence
H3K36me3 accumulates with repeated
rounds of transcription explaining why this
mark can not only predict sites but also
rate of transcription [Barski et al., 2007;
Bell et al., 2007; Buratowski and Kim,
2011; Edmunds et al., 2008; Mikkelsen
et al., 2007; Pokholok et al., 2005; Wag-
ner and Carpenter, 2012]. In dividing cells
new nucleosomes that are not H3K36 tri-
methylated are deposited during genome
replication. This is expected to dilute the
prevalence of H3K36 methylation while this
modification should further accumulate in
non-dividing cells. In turn rate of cell divi-
sion might influence the ability to predict
mRNA levels from this modification. A po-
tential accumulation of H3K36me3 in non-
dividing cells could lead to higher sensitivity
to predict transcription at weakly expressed
genes and, in case all available residues are
modified, to saturation and reduced predic-
tive power at highly expressed genes. To
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test the hypothesis of different H3K36me3
signal in dividing versus non-dividing cells
we group genes according to their mRNA
abundance into low and high expressed and
correlate their mRNA levels with the abun-
dance of the transcription coupled mark
H3K36me3 along the gene body (Figure
3.8). In the dividing cell types ES and NP
this mark shows highest predictive power
for highly expressed and reduced sensitiv-
ity for lowly expressed genes. However in
post-mitotic neurons there is a clear shift:
in these cells predictability is now highest
for low expressed genes in comparison to
highly expressed genes. This is fully com-
patible with a model whereby chromatin
modifications such as H3K36me3 integrate
transcriptional activity over time and that
the resulting signal is diluted with every
cell division. In turn the sensitivity range
changes in non-dividing cells, where signal
for H3K36me3 accumulates above detec-
tion threshold for lowly expressed genes but
also saturates for highly expressed genes.
Regulatory differences between tissue-
specific and housekeeping genes
Genes can be classified according to their
expression characteristics between cell types
and tissues. Figure 3.9 shows a histogram
of the number of tissues with detectable
mRNA abundance (log2 intensity > 7) for
the same set of genes studied in 72 tis-
sues and cell types profiled in the SymAt-
las project (Su et al., 2004). This re-
veals a clear bimodal distribution where
genes show either widespread activity (ex-
pressed in most samples, also referred to as
“housekeeping” genes) or selective activity
in only up to five samples (also referred to
as “tissue-specific”). This global behavior
is also evident in the stem cell to neuron
differentiation that we study here, where
genes with widespread activity according to
SymAtlas are enriched for genes that are
expressed in both cell types, while tissue-
specific genes tend to be expressed in either
one or none of the two studied cell types
(p-value < 2.2e-16, see supplemental infor-
mation section 10 for details). Importantly
previous studies already noted that these
two classes of genes differ in their regula-
tion: housekeeping genes are mostly under
the control of CpG rich promoters, while
tissue-specific genes show a high frequency
of CpG poor promoters [Mohn et al., 2008;
?]. These two classes of genes are differ-
entially occupied by histone modifications
[She et al., 2009], show different exon den-
sity [Eisenberg and Levanon, 2003; Vino-
gradov, 2004] and differ in 3’UTR length
and sequence composition making them un-
equal targets for microRNAs [Stark et al.,
2005]. To ask if these classes of genes also
differ in the relative regulatory contribu-
tion of transcriptional and posttranscrip-
tional layers we compared the predictabil-
ity of mRNA levels for tissue-specific and
housekeeping genes using an identical lin-
ear model approach as described above. In
this model, tissue-specific genes show more
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Figure 3.9: Post-transcriptional regulation in tissue-specific and ubiquitously expressed genes. (A) His-
togram of the number of cell or tissue types with detectable expression of the analyzed genes. Genes
are grouped in tissue-specific (expressed in 1-5 tissues, purple), intermediate (grey), and ubiquitously
expressed (expressed in 70 or more tissues, green). (B) Genes are classified into five equal groups
according to predicted transcription rate (0-100for genes with different tissue expression (as in (A),
color- coded). At a given level of transcription tissue-specific genes have on average less measured
mRNA than ubiquitously expressed genes, suggesting that the degree of post-transcriptional regulation
is higher in tissue-specific genes.
negative deviation from the fit, correspond-
ing to observed mRNA levels being lower
than predicted based on the transcriptional
features (Figure 3.9). We conclude that
tissue-specific genes are more prominently
controlled by post-transcriptional regula-
tion than housekeeping genes.
3.1.3 Discussion
In our study we tried to quantify the relative
contribution of transcriptional and post-
transcriptional regulation to mRNA levels.
We show that tri-methylation of lysine 36 of
histone H3, a chromatin modification that
is set co- transcriptionally, provides a quan-
titative measure of the process of RNA syn-
thesis. We built a linear model that com-
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bines H3K36 tri-methylation with other his-
tone marks and Pol-II occupancy to predict
transcription and to relate it to mRNA lev-
els. This reveals a high correlation between
predicted transcription based on chromatin
and actual mRNA abundance in both divid-
ing pluripotent cells and terminally differen-
tiated neurons suggesting that transcription
and mRNA levels are tightly linked at differ-
ent cellular stages. These findings are con-
sistent with two recent studies comparing
direct measures of transcription with mRNA
abundance [Rabani et al., 2011; Schwan-
ha¨usser et al., 2011]. Furthermore we in-
vestigated the predictive power of histone
marks towards changes in mRNA levels be-
tween the two cell types and find similarly
that transcription is also the main deter-
minant when looking at genes that change
their mRNA levels. Following the deter-
mination of transcriptional contribution we
investigated the contribution of different
post-transcriptional processes by extending
the model to include information on mi-
croRNA targeting and transcript half-life.
The effect of transcript half-life is indeed
detectable on a genome-wide scale explain-
ing minor additional variance of mRNA lev-
els. Notably however we can also detect this
minor contribution when we look at the pre-
dictive power of half-life towards changes
in mRNA levels from ES to TN. Reliable
reproduction of the effect of degradation
for changes in mRNA levels suggests that
the method to measure half-life is sensi-
tive. Moreover, this supports that degra-
dation indeed plays a small but measur-
able role in determining mRNA levels and
changes. Targeted degradation of mRNA
by the action of microRNAs affects actual
half-lives of mRNAs [Guo et al., 2010]. Im-
portantly however we could not detect the
actual effect of microRNA at a genome-
wide scale, but only in a subset of high-
confidence microRNA targets. This pre-
cludes correct quantification of the con-
tribution of microRNA regulation to to-
tal mRNA decay. However, when focus-
ing only on those genes that are highly up-
regulated in cells that lack Dicer we ob-
serve that microRNAs can explain about
2.25% of the residual variance. Extrapo-
lating this contribution to all genes as a
fraction of the total measured mRNA de-
cay effect, we can estimate that microRNAs
contribute between 2.5 and 25% to the total
mRNA decay. This effect is compatible with
the notion that microRNAs generally cause
small changes in mRNA abundance [Babi-
arz et al., 2008; Sinkkonen et al., 2008].
At the same time we foresee that the inher-
ent complexity in correctly predicting mi-
croRNA targets leads to an underestima-
tion of the actual effect. The relatively
low contribution of post-transcriptional reg-
ulation on the mRNA levels and changes
shows that that the lion’s share of regula-
tory contribution is at the level of mRNA
synthesis and predictable from chromatin
alone. It is important to note that the iden-
tified quantitative contribution (the frac-
tion of explained variance), while important
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for understanding the regulatory principles,
does not translate to functional relevance
and thus should not be taken as a mea-
sure for biological importance. For exam-
ple, the Dicer−/− cells used here to iden-
tify microRNA-targets lack the ability to
differentiate into neurons. The low quan-
titative contribution of post-transcriptional
processes is however compatible with the
model that these mostly function in fine-
tuning mRNA levels rather than function-
ing as on-off switches [Mukherji et al.,
2011]. Our study shows that chromatin
is highly predictive of transcriptional out-
put, in particular methylation of lysine 36
of H3, a mark that is set throughout the
gene body and depending on the elongating
polymerase. Most other histone marks that
are involved in transcription occur primarily
at promoters and, such as K4 methylation
of CpG islands, can even occur at a sub-
class of promoters without activity of the
linked gene, which in turn limits their pre-
dictive power [Weber et al., 2007]. Inter-
estingly H3K36me3 is a far better predic-
tor than RNA polymerase itself. We believe
that this reflects the fact that the histone
mark is stable once it is set, while the poly-
merase rapidly elongates and thus is only
present at the gene at low frequency. While
it is inherently difficult to directly compare
the performance of H3K36me3 with direct
labeling approaches for ongoing transcrip-
tion we note that the correlation between
H3K36me3 and steady-state mRNA levels
is higher at all three cell states than at
recent reports using alternative approaches
like GRO-seq (r2 = 0.62 [Min et al., 2011]).
One likely explanation for the high predic-
tive power of H3K36me3 is that it increases
with every round of transcription, which
in turn means that it can eventually sat-
urate, when all possible lysines are methy-
lated. In dividing stem cells such satura-
tion is not observed, likely due to the “di-
lution” of modified histones that occurs at
every S-phase during genome duplication in
addition to the general turnover of nucleo-
somes [Deal and Henikoff, 2011; Wirbelauer
et al., 2005]. In post-mitotic cells however
we indeed observe such saturation at highly
expressed genes. At the same time the ac-
cumulation of signal increases the sensitiv-
ity for the detection of weakly expressed
genes, which in the linear model compen-
sates for the reduced predictability at highly
expressed genes.
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Cell Culture
Wild-type embryonic stem cells (129Sv-
C57Bl/6) were cultured and differentiated
as previously described (Bibel et al., 2007;
Mohn et al., 2008).
Chromatin Immunoprecipitation (ChIP)
Cells were cross-linked in medium con-
taining 1as described before (Mohn et
al., 2008), starting with 70µg of chro-
matin and 5µg of the following anti-
bodies: anti-dimethyl-H3K4 (Upstate, no.
07-030 (Lienert et al., 2011; Tiwari et
al., 2012), anti-trimethyl-H3K36 (Abcam
ab9050), anti-trimethyl- H3K27 (Upstate,
no. 07-449) (Lienert et al., 2011; Tiwari et
al., 2012) anti- RNA-polymerase-II (Santa
Cruz Biotechnology, no. SC899) (Lienert et
al., 2011; Tiwari et al., 2012). Chromatin
was sonicated for 10 cycles of 30 sec using
a Diagenode Bioruptor. Precipitated DNA
was subjected to next generation sequenc-
ing.
Next generation sequencing
5 to 10 ng of precipitated DNA was pre-
pared for Solexa Sequencing as described
(Mikkelsen et al., 2007). Briefly, ChIP DNA
was ligated to adapters and ligation prod-
ucts of about 250 bp were gel purified on 1.5
18 PCR cycles. DNA sequencing was car-
ried out using the Illumina/Solexa Genome
Analyzer II (GA2) sequencing system. In
addition 2 lanes of non-enriched chromatin
from ES cells were sequenced and pooled
to serve as an input/background to calcu-
late the enrichment of reads obtained from
ChIP-seq experiments. The raw .srf and
.wig files are accessible at GEO GSE33252
(reviewer link)
Genomic coordinates
The July 2007 M. musculus genome
assembly (NCBI37/mm9) provided by
NCBI http://www.ncbi.nlm.nih.gov/
genome/guide/mouse/ and the Mouse
Genome Sequencing Consortium http:
//www.sanger.ac.uk/Projects/M_
musculus/ was used as a basis for all anal-
yses. Annotation of known RefSeq tran-
scripts was obtained from UCSC.
Read filtering, alignment and weighting
Low-complexity reads were filtered out
based on their dinucleotide entropy as fol-
lows: For each read, the dinucleotide en-
tropy was calculated according to the for-
mula H =
∑
i filog(fi) , where fi is the
frequency of dinucleotide i in the read and
the sum is over all dinucleotides (i from
1 to 16). The read was filter out if its
H was less than half the dinucleotide en-
tropy of the genome, typically removing
less than 0.5% of the reads in a given sam-
ple. Alignments to the mouse genome were
performed by the software bowtie (version
0.9.9.1) [Langmead et al., 2009] with pa-
rameters -v 2 -a -m 100, tracking up to
100 best alignment positions per query
and allowing at most two mismatches. To
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track genomically untemplated hits (e.g.,
exon-exon junctions or missing parts in
the current assembly), the reads were also
mapped to an annotation database contain-
ing known mouse sequences (microRNA
from ftp://ftp.sanger.ac.uk/pub/
mirbase/sequences/13.0, rRNA,snRNA,
snoRNA and RefSeq mRNA from GenBank
http://www.ncbi.nlm.nih.gov/sites/
entrez, downloaded on July 16, 2009,
tRNA from http://lowelab.ucsc.edu/
GtRNAdb/ and piRNA from NCBI (acces-
sions DQ539889 to DQ569912). In that
case, all best hits with at most two mis-
matches were tracked. Each alignment
was weighted by the inverse of the num-
ber of hits. In the cases where a read had
more hits to an individual sequence from
the annotation database than to the whole
genome, the former number of hits was se-
lected to ensure that the total weight of a
read does not exceed one. All quantifica-
tions were based on weighted alignments.
For generation of wiggle files samples were
normalized for library size first and files were
generated with a window size of 100 bps.
RNA-Sequencing
Poly-A-RNA-seq: RNA from ES cells, NP
cells and TN was isolated using the Trizol
(Invitrogen). The sequencing libraries were
prepared according to mRNA-Seq Sample
Preparation Guide (Illumina) starting from
1µg of total RNA and using oligo dT
primers for selection of polyadenylated mR-
NAs. The libraries were sequenced on an Il-
lumina GA II analyzer. Ribosome-depleted-
RNA-seq: RNA was isolated from ES, cells
NP cells and TN using Trizol (Invitrogen)
followed by depletion of ribosomal RNA,
starting with 2µg of total RNA and follow-
ing the instructions of Ribo-Zero Kit (Epi-
centre). Strand specific RNA libraries were
prepared according to pre-release version of
the Directional mRNA-Seq Library Prepa-
ration guide (Illumina) and sequenced on
an Illumina GA II analyzer. Reads were
mapped to the Mus musculus transcriptome
and normalized to transcript length and se-
quencing library size. The raw .srf and .wig
files are accessible at GEO GSE33252
Small RNA sequencing
RNA of ES, NP and TN was isolated in trip-
licates from cell culture with mirVanaTM
microRNA Isolation Kit (AM1560) accord-
ing to the kit instructions. Small RNA was
prepared for sequening with Illumina Small
RNA Sequencing Kit (FC-102-1009) follow-
ing the Small RNA Sample Prep v1.5.0 pro-
tocol.
Linear model to predict transcription
rate
We used R (Team, 2011) and the func-
tion lm() to fit a linear model to describe
transcription rate. For every gene we se-
lected a representative transcript of median
length. Only transcripts, which did not
overlap with alternative transcripts with dif-
ferent TSS or transcripts in antisense di-
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rection, were kept for further analysis (sup-
plemental information section 2). ChIP-seq
reads of Pol-II, H3K4me3 and H3K27me3
were mapped to the TSS (+/- 500 bp) of
the representative transcript. H3K36me3
was mapped to 4 different regions along the
gene-body: (i) exons within first 2kb of the
transcripts, (ii) introns within the first 2kb
of the transcripts, (iii) exons located 2kb
downstream from the TSS, (iv) introns lo-
cated 2kb downstream from the TSS, (sup-
plemental information section 3). Input
chromatin sequencing reads were mapped
to the whole gene body and used as an addi-
tional regressor to account for amplification
and sequencing biases caused by the DNA
sequence itself. These 7 regressors were
fitted to mRNA levels as response value
(mean read count of poly-A-enriched RNA-
sequencing and strand-specific-sequencing)
with 2-fold-cross validation. The squared
pearson correlation coefficient corresponds
to the explained variance in the response
variable (Achen, 1982).
Transcript half-life measurement
ES cells and TN of two independent bio-
logical replicates were treated with actino-
mycin D as previously described (Sharova et
al., 2009). RNA was isolated from an equal
number of cells with Trizol at 1,2,4, and
8 hrs after treatment. 100ng of extracted
total RNA was amplified using the Ambion
WT Expression kit (Ambion) and the re-
sulting sense-strand cDNA was fragmented
and labeled using the Affymetrix GeneChip
WT Terminal Labeling kit (Affymetrix).
Affymetrix GeneChip arrays were hybridized
following the GeneChip Whole Transcript
(WT) Sense Target Labeling Assay Man-
ual (Affymetrix) with a hybridization time
of 16h. The Affymetrix Fluidics pro-
tocol FS450-0007 was used for washing.
Scanning was performed with Affymetrix
GCC Scan Control v. 3.0.0.1214 on a
GeneChip® Scanner 3000 with autoloader.
Subsequently arrays were normalized with
RMA, without in between normalization to
preserve absolute mRNA abundance. Decay
slope of every transcript was inferred with
a linear model and only transcripts with re-
liably inferable slopes (R>=0.4) were kept
for further analysis. Transcripts half-lives
were calculated from the mRNA abundance
over time according to (Sharova et al.,
2009) (see supplemental information sec-
tion 5 for detailed description). The raw
.CEL files and a table with normalized ex-
pressions are accessible at GEO GSE33252.
To confirm our results obtained by acti-
nomycinD treatment we infer mRNA half-
life by metabolic labeling of nascent RNA
adapted from the protocol described in
[Do¨lken et al., 2008]. RNA was isolated
with trizol, using 30µg RNA (a final concen-
tration of 120ng/µl) for the biotinylation,
followed by 2 chloroform/IAA extractions
on the bio tagged RNA. Non-denaturated
RNA is used in the IP with Dynabeads M-
280 Streptavidin (112.06D, Invitrogen) for
pull down (50µl /30µg RNA), followed by
one elution step with DTT. See supplemen-
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tal information section 6, for experimental
details, analysis and results. The raw .CEL
files and a table with normalized expressions
are accessible at GEO GSE33252
Data Accession
All the data used in this study is accessible
at GEO in the superseries GSE33252
Reviewer Link to GEO superset
GSE33252: http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?token=
jzchtusugkqcwbo&acc=GSE33252
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3.2.1 Definition of the model
As a general model of production and degradation contribution to mRNA abundance we
can formulate:
dR
dt
= txj [DNA]− dj [RNAj ] (3.2)
Importantly all measures of mRNA abundance and chromatin readouts of transcription are
log transformed to be able to use them in a linear regression.
Therefore tx is log10(transcription rate of gene j) and d is log10(degradation rate). [DNA]
and [RNA] are both concentrations, where [RNA], log10(RNA abundance of gene j), de-
pends on the gene j and [DNA] = 1.
At equilibrium dRdt = 0 and we can write:
txj [DNA] = dj [RNAj ] (3.3)
Because [DNA] = 1 we can write:
txj = dj [RNAj ] (3.4)
Therefore, if we are speaking about one cell type, where mRNA concentrations are not
changing, we are in an equilibrium. In this case the transcription rate txj is proportional to
RNA concentration [RNAj ].
Note that for the first part, talking about transcriptional regulation, we assume the degra-
dation rate to be independent of the gene j and therefore, for the first part dj is a constant.
In the second part, when we introduce post-transcriptional regulation into the model, we
allow dj to be dependent on the gene j and actually infer the gene dependent degradation
rates experimentally.
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3.2.2 Selection of representative transcripts
For each RefSeq annotated gene in the mouse genome, a representative transcript of median
length was selected. For the whole analysis described in the paper we only used RefSeq
transcripts, which do not overlap with an anti-sense transcript and do not overlap with any
transcript containing an alternative transcription start site. About half of the mouse genes
fulfill these criteria ( 10.000 genes).
Supplemental Figure 3.1: Scheme illustrating transcript selection for the analysis performed in the
paper.
Regions to infer regressors for the linear model
Sequencing reads from ChIP-seq experiments where mapped to different regions, depend-
ing on where the histone modification of interest is most predictive for mRNA levels.
H3K27me3, H3K4me2 and pol-II were mapped to the TSS while H3K36me3 was mapped
to 4 independent regions due to the distribution pattern of this modification (Figure 2).
Supplemental Figure 3.2: Enrichment of H3K36me3 along the first 6 kb into the transcript. X-axis
shows position relative to TSS, y-axis shows enrichment over input. The reads were separately mapped
to exonic (blue) and intronic (green) regions. Enrichment in exons is generally higher than in introns,
however because exons are shorter, they bear less total reads leading to a more noisy signal in the
metagene plot.
H3K36me3 is set by the elongating RNA polymerase. The signal increases over the
first 2 kb starting from TSS and remains throughout the gene body. Exons and introns
have different H3K36me3 levels, possibly due to their different sequence compositions. We
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account for this locally different H3K36me3 patterns by separating the signal in 4 different
bins (Figure 3).
Supplemental Figure 3.3: Illustralion of regions relative to TSS used to map ChIP reads: Pol-II,
H3K27me3 and H3K4me2 were mapped to TSS (purple). H3K36me3 was mapped separately to TSS
proximal and genebody, to exons (blues) and introns (greens) respectively.
Supplemental Figure 3.4: H3K36me3 mapped to the 4 different regions within the genes (Figure 3)
and correlated to the mRNA levels of the respective gene. H3K36me3 levels over the exons located
2kb upstream of the TSS to the end of the gene body are most predictive for mRNA levels.
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3.2.3 Estimation of error in the linear model
Estimation of Error in the Linear Model in one Cell Type
The Problem
We want to model mRNA levels as linear function of the levels of 3 histone marks and RNA
polymerase II occupancy at the corresponding gene’s locus. To both fit and test this model,
we measured mRNA expression, Pol2 occupancy, and the 3 histone marks in duplicate dur-
ing differentiation of mouse embryonic stem cells into post-mitotic glutamatergic neurons.
Importantly, a separate biological replicate differentiation was used for each measurement.
In this note we use the variation across replicate measurements to estimate the noise on
our estimates of mRNA and chromatin mark levels, and derive the maximal fraction of the
observed variation in mRNA levels that could potentially be explained by the model, i.e.
taking into account variation that is due to noise.
The linear model and its relative error
For the quantification of mRNA levels we count the reads over annotated refSeq genes.
For histone marks H3K27me3, H3K4me2 and Pol-II-IPs we count the reads in a 1kb region
around the TSS. H3K36me3 is measured in 4 separate regions: exonic and intronic TSS
proximal region (0-2kb downstream of TSS) and exotic and intronic gene body region. All
values are log2 transformed (pseudo count=1).
Let mi denote the log2 transformed level of mRNA i, and let hc,i denote the log2
transformed level of histone mark c at gene i. We fit a linear model of the form
mi = c+
∑
h
αhhc,i, (3.5)
where c is a constant and αh are the linear coefficients that we estimate when fitting the
model. c = 〈m〉 −∑h αh〈hc〉, where 〈m〉 is the mean mRNA level. At a given time point,
the expression levels mi show a variation that is given by
var(m) =
1
N
N∑
i=1
(mi − m¯)2 , (3.6)
where N is the total number of genes and m¯ is the average mRNA level
m¯ =
1
N
N∑
i=1
mi. (3.7)
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We now want to compare the variance var(m) with the average squared-deviation (the
‘error’) between the model and the true mRNA levels. This error is defined as
D2 =
1
N
N∑
i=1
(
mi − c−
∑
c
αchi,c
)2
. (3.8)
The fraction of the variance f that is explained by the model can now be defined as
f =
var(m)−D2
var(m)
. (3.9)
Note that for a perfect model D2 = 0 so that f = 1, and for a model that just predicts
mi = m¯, i.e. just the average for every gene, we have f = 0.
Measurement and biological replicate noise
In equation (3.5), the quantities mi and hc,i denote the ‘true’ mRNA and chromatin mark
levels at a particular stage of differentiation, which can be thought of as the mean levels
in the population of cells, averaged over a large number of biological replicates. However,
we do not have direct access to these levels, we only have duplicate measurements from
different experimental replicates. As a consequence, part of the deviations between the
measured mRNA levels and the predicted levels in terms of the measured chromatin mark
levels will be due to deviations between the true and measured levels.
Let m1i and m
2
i denote the duplicate measurements of the mRNA level of gene i. These
values will differ from the ‘true’ mRNA level mi by some unknown amount i, i.e.
m1i = mi + 
1
i , (3.10)
and similar for m2i . Note that the deviation 
1
i includes both biological ‘noise’ from variations
in levels across the biological replicates, as well as measurement noise. Note also that, per
definition, the expectation value of the deviation is zero
〈1i 〉 = 0. (3.11)
The size of the noise is characterized by the variance of the deviations, i.e. we define
σ2i = 〈(1i )2〉 = 〈(2i )2〉. (3.12)
In our model we will allow different genes i to have different sized variations across the
replicates.
For the chromatin marks we similarly write
h1i,c = hi,c + 
1
i,c, (3.13)
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and
σ2c,i = 〈(1i,c)2〉 = 〈(2i,c)2〉. (3.14)
A key assumption that we will make is that, the values of the deviations ji and 
j
i,c are
all mutually independent. This is a highly reasonable assumption since these measurements
derive from separate biological replicates. That is, all covariances are zero, e.g.
〈ji ki,c〉 = 0, (3.15)
for all j, k and c.
Estimating the noise levels
We can use the replicate measurements to both estimate the true values mi and hi,c, as
well as estimate the size of the noise σ2i and σ
2
i,c. In particular, given the measured values
m1i and m
2
i , the expected value of mi is simply given by the mean
〈mi〉 = m
1
i +m
2
i
2
, (3.16)
which we will also refer to as m¯i. Similarly, the expected variance 〈σ2i 〉 is given in terms of
the difference of the measurements, i.e.
〈(m1i −m2i )2〉 = 〈(1i − 2i )2〉 = 〈(1i )2〉+ 〈(2i )2〉+ 2〈(1i 2i )〉 = 2σ2i , (3.17)
where we have used that the covariance is zero, i.e. 〈1i 2i 〉 = 0. From this we have the
estimate
σ2i =
1
2
〈(m1i −m2i )2〉. (3.18)
In complete analogy, we have for the estimated chromatin mark levels
〈hi,c〉 =
h1i,c + h
2
i,c
2
= h¯i,c, (3.19)
and for the noise levels of the chromatin marks
σ2i,c =
1
2
〈(h1i,c − h2i,c)2〉. (3.20)
Finally, we can define the average noise levels across all genes as
σ2 =
1
N
N∑
i=1
σ2i , (3.21)
and
σ2c =
1
N
N∑
i=1
σ2i,c. (3.22)
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Estimating the variance in mRNA levels
We cannot directly measure the variance var(m) in mRNA levels, but we can calculate the
observed variation V 2 in measured mRNA levels. Defining
m¯ =
1
N
N∑
i=1
m¯i, (3.23)
we have
V 2 =
1
N
N∑
i=1
(m¯i − m¯)2 . (3.24)
Writing m¯i in terms of the true level mi and the deviations due to replicate fluctuations
and measurement error, we have
〈V 2〉 = 1
N
〈
(
mi − m¯+ 
1
i + 
2
i
2
)2
〉. (3.25)
Using the fact that the cross-correlations are zero we have
〈V 2〉 = var(m) + 1
2
σ2. (3.26)
As a technical note, we have here neglected the deviation of the measured average mRNA
level m¯ from the true average level (1/N)
∑
imi. Taking this into account would lead to
corrections of order 1/N , which are negligible in practice.
We can thus estimate the true variance var(m) in terms of the measured variance V 2
as
var(m) = V 2 − 1
2
σ2. (3.27)
Estimating the error of the model
To estimate the error in the model, we compare the estimated mRNA levels m¯i with the
predicted ones based on the chromatin marks h¯i,c. We define the average squared-deviation
as
T 2 =
1
N
N∑
i=1
(
m¯i − c−
∑
c
αch¯i,c
)2
. (3.28)
We can write the expectation of this quantity 〈T 2〉 in terms of the true deviation between
model and mRNA levels for each gene i, i.e.
Di = mi − c−
∑
c
αchi,c, (3.29)
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and the noise due to biological replicate variations and measurement errors. That is, we
have
〈T 2〉 = 1
N
N∑
i=1
〈
(
Di +
1i + 
2
i
2
−
∑
c
αc
1i,c + 
2
i,c
2
)2
〉. (3.30)
Using that the covariances between all different noise terms are zero, and making the final
assumption that there are no correlations between the true deviations Di and the noise
levels, e.g.
〈Diji,c〉 = 0, (3.31)
we find that all cross-terms are zero and we have
〈T 2〉 = D2 + 1
2
σ2 +
1
2
∑
c
α2cσ
2
c . (3.32)
Since we can measure T 2, and we have above derived expressions for the noise levels σ2
and σ2c in terms of the duplicate measurements, we can thus estimate the true deviation
D2, i.e.
D2 = T 2 − 1
2
σ2 − 1
2
∑
c
α2cσ
2
c . (3.33)
Putting it all together, we finally estimate the fraction of explained variance as
f =
V 2 − T 2 + 12
∑
c α
2
cσ
2
c
V 2 − 12σ2
. (3.34)
Error in the model of the expression changes across two cell types ∆TN,ES
Instead of explaining absolute mRNA levels we also want to use a linear model to predict the
changes in expression levels between the embryonic stem cell and neuron stage. Specifically,
we will model the log fold-change ∆i,m in mRNA expression level of each gene i. All
values are log transformed, ’TN-ES’ therefore stands for a log ratio, log(TN)− log(ES) =
log(TN/ES).
1
N
∑
i
(mi(TN)−mi(ES)− m¯(TN) + m¯(ES))2 (3.35)
Linear model of expression changes
∆i,m = mi(TN)−mi(ES), (3.36)
in terms of the changes ∆i,c in chromatin marks
∆i,c = hi,c(TN)− hi,c(ES) (3.37)
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using a linear model. That is, in complete analogy with our previous linear model we write
∆i,m = c˜+
∑
c
α˜c∆i,c. (3.38)
Measurement and replicate noise
We use the same replicate measurements to estimate the changes ∆i,m and ∆i,c. Impor-
tantly, individual measurements are coming from separate biological replicates so that our
assumption that the cross-correlation of deviations are expected to be zero still holds.
We thus estimate the change ∆i,m by averaging over the duplicate measurements, i.e.
∆¯i,m =
m1i (TN) +m
2
i (TN)−m1i (ES)−m2i (ES)
2
, (3.39)
and similary for the chromatin marks
∆¯i,c =
m1i (TN) +m
2
i (TN)−m1i (ES)−m2i (ES)
2
. (3.40)
We estimate the noise levels in our estimates ∆¯i,m and ∆¯i,c at both time points using
the replicates exactly as described above. That is, we have
〈σ2i,m(ES)〉 =
1
2
(
m1i (ES)−m2i (ES)
)2
, (3.41)
〈σ2i,m(TN)〉 =
1
2
(
m1i (TN)−m2i (TN)
)2
, (3.42)
〈σ2i,c(ES)〉 =
1
2
(
h1i,c(ES)− h2i,c(ES)
)2
, (3.43)
and
〈σ2i,c(TN)〉 =
1
2
(
h1i,c(TN)− h2i,c(TN)
)2
. (3.44)
The variance in expression changes
We again estimate the true variance of expression changes
var(∆m) =
1
N
N∑
i=1
(
∆i,m − ∆¯m
)2
, (3.45)
with
∆¯m =
1
N
N∑
i=1
∆i,m, (3.46)
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from the observed variance of the measured expression changes
V 2 =
1
N
N∑
i=1
(
∆¯i,m − ∆¯m
)2
. (3.47)
Writing the measured gene expression changes ∆¯i,m in terms of the true values ∆i,m
and the deviations, and using that cross-correlations are zero, we obtain
〈V 2〉 = var(∆m) + 1
2
σ2i,m(ES) +
1
2
σ2i,m(TN). (3.48)
Using this we thus estimate the true variance in expression changes as
var(∆m) = V
2 − 1
2
σ2i,m(ES)−
1
2
σ2i,m(TN). (3.49)
Error in the model
We again define the true deviation between predicted and true expression change for gene
i as
Di = ∆i,m − c˜−
∑
c
α˜c∆i,c, (3.50)
and want to estimate the true average squared-deviation
D2 =
1
N
N∑
i=1
(Di)
2 . (3.51)
The observed total deviation between measured and predicted levels is given by
T 2 =
1
N
n∑
i=1
(
∆¯i,m − c˜−
∑
c
α˜c∆¯i,c
)2
. (3.52)
Writing the measured expression changes ∆¯i,m and chromatin mark changes ∆¯i,c in terms
of the true changes and deviations, and using that the cross-correlations in the deviations
are zero, we obtain
〈T 2〉 = D2 + 1
2
σ2i,m(ES) +
1
2
σ2i,m(TN) +
1
2
∑
c
α˜2c
(
σ2i,c(ES) + σ
2
i,c(TN)
)
. (3.53)
From this we estimate the true average squared-deviation as
D2 = T 2 − 1
2
σ2i,m(ES)−
1
2
σ2i,m(TN)−
1
2
∑
c
α˜2c
(
σ2i,c(ES) + σ
2
i,c(TN)
)
. (3.54)
Combining these results we finally estimate the fraction f of expression-change that can
possibly be explained by the model as
f =
V 2 − T 2 + 12
∑
c α˜
2
c
(
σ2i,c(ES) + σ
2
i,c(TN)
)
V 2 − 12σ2i,m(ES)− 12σ2i,m(TN)
. (3.55)
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3.2.4 Calculation of transcript half-life by actinomycinD treatment
RNA was isolated from a fixed number of cells in culture (ES cells as well as Neurons) and
subjected to Affymetrix ST 1.0 Mouse Gene Arrays. The raw data was processes with R’s
’oligo’ package, RMA was used without normalization. Expression values were aggregated
on transcript level and degradation rates of each transcript were estimated using linear
regression of the log (log2) transformed signal intensity values y versus time t.
y = n−mt (3.56)
where t is time, m is the slope, n is the intercept and d = m ∗ ln(2) is the decay rate.
Using R’s ’limma package’ we calculate log2 fold-changes from t=0 to t=8 in duplicates
Supplemental Figure 3.5: (A) Duplicates of mRNA abundance measurements (orange, blue) in a
time-course after actinomycinD treatment. For each experiment the log2 transformed values of all
transcripts are summarized in a boxplot. Overall mRNA abundance decreases over time. (B) Raw
mRNA abundance in log2 as a function of time after actinomycinD treatment for a single transcript.
Measurement and linear regression in duplicates (orange and blue).
and infer the p-value for each. The resulting ’vulcano plot’ is shown in Figure 2. Assuming
a p-value of 0.01 (1 false in 100) the vast majority of genes with a log2 fold-change lower
than -0.4 show significantly decreased levels in the time interval from 0 to 8 hrs to be
considered. The slope m of these genes is calculated by:
m =
∆y
∆x
=
logFC
∆time
=
−0.4
8h
= −0.05 (3.57)
The corresponding half-life τ to the slope m of -0.05 is calculated by:
τ =
−1
m
=
−1
−0.05 = 20h (3.58)
This value of 20 hrs corresponds to an upper limit that we select for the extrapolation of
half-lives based on a time-course experiment covering an interval of 8 hours.
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Supplemental Figure 3.6: Vulcano plot showing log fold-change from time point t=0 to time point
t=8 on the x-axis versus corresponding p-values from replicates. Intersection of red lines at -0.4 log
fold-change with p-value of 0.01.
Supplemental Figure 3.7: Short-lived transcripts are polyA-depleted. (A) PolyA depleted transcripts
were identified contrasting mRNA sequencing with following polyA selection (x-axis) and mRNA se-
quencing following ribosomal RNA depletion without polyA enrichment (y-axis). Reads present in the
non-polyA-selected experiment, which are not present in the polyA-selection are defined as non-polyA
transcripts (orange). (B) Box-plot showing the shift in transcript half-life comparing polyandenylated
(grey) and non-polyadenylated (orange) transcripts.
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Supplemental Figure 3.8: Scatter plot of linear-model derived transcription rate (x-axis) and measured
mRNA levels (y-axis). Both are log2 transformed read-counts. This plot illustrates i) that mRNA levels
are less well modelled in low transcribed regions (corresponding to bin <20transcribed genes are depleted
of short lived-genes (therefore the box-plot in Figure 2C in the leftmost bin can be misleading)
Supplemental Figure 3.9: Correlation of the model’s residuals with the respective measure of post-
transcriptional regulation. (A) Histogram of the residuals of the linear model. Colors indicate grouping
of residulas in bins of equal size, this binning also applies for B,C and D. (B) Boxplot showing the
correlation of mRNA half-life versus the residual of the linear model. Pearson correlation shown on top
is 0.29, which means that almost 30% of the residual variation in mRNA levels can be explained by
mRNA half-life.
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3.2.5 Calculation of transcript half-life by metabolic labeling
We treated ESCs with medium containing thioU in a final concentration of 200µM for 1hr.
RNA was isolated with Trizol. 4sU-labeled RNA was biotinylated using EZ-Link Biotin-
HPDP (Pierce) and streptavidin IP was performed to separate the labeled RNA fraction.
To recover the unlabeled RNA the flow-through was collected. RNA was recovered from
the washing fractions and eluates using the RNeasy MinElute Spin columns (Qiagen).
Supplemental Figure 3.10: Dot blot assay according to Doelken et al. 2008. Exposure 20 mins
shown. Cells were treated for 60 mins with different concentrations of ThioU. We did not observe a
difference in flourescence of labeled RNA between the two highest concentrations, therefore we choose
200µM as reported before in Doelken et al. 2008 for our experiment.
Experiment was done in biological triplicates. All three fractions of each replicate, RNA,
total RNA, labeled and un-labeled RNA, were subjected Affymetrix Gene Arrays. All arrays
(triplicates of total, labeled and unlabeled RNA) were normalized together by RMA and
summarized on transcript level. Transcripts with RMA intensities less than 5 on linear scale
were discared. To account for the relative measurement of the microarrays we calculate
correction factors for the ratios (labeled/total RNA) and (unlabeled/total RNA) accoring
to Doelken et al. 2008, for each of the triplicates separately. In addition we account for the
U-bias in the IP (described in Schwannhaeuser et al. 2011) by normalizing to ’U’ density
of the transcript. RNA half-lives are subsequently calculated for each replicate assuming
exponantial decay:
T1/2 = −t ∗
ln(2)
ln(1− 1
1+
(labeled/total)
(unlabeled/total)
)
(3.59)
were −t is the labeleing time. As decribed in Doelken et al. we use t =55mins assuming
the thioU labeling starts 5 mins after addition of thioU to the medium.
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Supplemental Figure 3.11: Transcript half-life calculated from biological triplicates of total-, newly
synthetized and preexisting RNA. Shown are pairwise comparisons and their pearson correlations.
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Supplemental Figure 3.12: RNA half-life derived by metabolic labeling was integrated in the linear
model predicting transcription. The upper boxplots show half-lifes derived by actinomycinD treatment
(left) and thioU treatment (right) agains the residual of the linear model. Both half-life measures can
explain the remeining variance (residual) to the same extend, pearson correlation shown above the
plot respectively. Correlation beweeen the two half-life measures shown in the scatterplot below. The
histogram shows half-life distribution derived by thioU treatment. The lower plot shows mRNA half-life
in the context of predicted transcription and measured mRNA level. Lower mRNA level in the same
transcription bin can be explained by mRNA half-life derived by thioU treatment, in accordance with
out actinomycinD derived data.
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3.2.6 MicroRNA target determination by Dicer knockdown
Supplemental Figure 3.13: Correlation of the model’s residuals with the respective measure of post-
transcriptional regulation. Histogram of the residuals of the linear model. Colors indicate grouping of
residulas in bins of equal size, this binning also applies for B,C and D. Boxplot showing the correlation
of the log fold-change between Dicer knockout Dicer +/- cells versus the residual of the linear model.
Pearson correlation shown on top is 0.01, which means that 1% of the residual variation in mRNA
levels can be explained by a miRNA-target definition based on Dicer KO data.
Supplemental Figure 3.14: Box Plots for different cut-offs of log fold-changes upon Dicer KO (y-axis)
versus the residual of the linear model (x-axis). The color separates genes with positive (purple) or
negative (orange) logFC upon Dicer KO. If the log fold-change is negative, the level of the respective
mRNA is higher in Dicer -/- cells. These mRNA should be the ones affected by miRNAs and therefore
we expect their residual to be negative. Hence we expect an increasing anti-correlation the higher the
cut-off in absolute log fold-change. This increasing shift of the two groups can be observed for cut-offs
of log fold- changes of: (A) 0, (B) 0.5, (C) 0.7, (D) 0.9, (E) 1.1, (F) 1.3, (G) 1.5, (H) 1.7, (I) 1.9
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3.2.7 MicroRNA target determination by calculation of iMir score
For the representative mRNA of each refSeq gene we calculated a score, which reflects
the probability of this mRNA to be down regulated by miRNAs, here called iMir score.
This score is influenced by two factors: (A) the posterior probability of a miRNA to bind
a specific target sequence in the 3’ UTR of the mRNA and (B) by the abundance of the
miRNA in the respective sample. The posterior probability of a miRNA to bind a specific
target sequence was adapted from the EIMMo algorithm (Gaidatzis et al. 2007). MiRNA
abundance in the three cell types ES, NP and TN was measured in triplicates by small RNA
sequencing (see methods). The iMir score is a sum of all the posterior probabilities of a
miRNA target site in a mRNA weighted by the abundance of the miRNA and summed up
for each mRNA. Formally we can write the iMir score for one mRNA as:
iMirmRNA =
N∑
n=1
ppn ∗ expmiRNAn (3.60)
where N is the number of possible mRNA-miRNA interactions in a given 3’ UTR and exp
is the expression (abundance) of the respective miRNA involved in this interaction.
Consequently an mRNA will have a high iMir, or likely being down regulated by miRNAs,
if there are many possible binding sites, the posterior probability of each binding site is high
and the abundance of the possibly binding miRNAs is high.
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Supplemental Figure 3.15: Effect of targeting by miRNAs on mRNA levels. (A) Scheme illustrating
the components used in the calculation of the iMir value, a measure for the likelihood of an mRNA
to be regulated by miRNAs. (B) Distribution of the logarithmic iMir value. Genes are grouped by
iMir value into five equal groups indicated by color. (C) Genes are classified into five equal groups
according to predicted transcription rate (0-100%), and within each group measured mRNA levels are
shown as boxplots separately for genes with different iMir values (as in (B), color-coded). Within a
given transcription group, predicted miRNA-target genes (iMir ‘HIGH’) have similar mRNA levels as
other genes.
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Supplemental Figure 3.16: Correlation of the model’s residuals with the respective measure of post-
transcriptional regulation. Histogram of the residuals of the linear model. Colors indicate grouping of
residulas in bins of equal size, this binning also applies for B,C and D. Boxplot showing the correlation
of the logarithmic iMir value versus the residual of the linear model. Pearson correlation shown on top
is -0.04 (note that here we expect the correlation to be negative, as the more negative the residual, the
higher the iMir value), which means that 4% of the residual variation in mRNA levels can be explained
by a miRNA-target definition based on in-silico target prediction.
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Supplemental Figure 3.17: Focus on high-confidence miRNA target genes. (A) Same plot as in Figure
1C. All refSeq genes are classified according to their iMir value as in Supplementary Figure 1B. (B)
Subset of all the genes in (A) with log2(iMir) values higher than 4. This subset contains genes that are
more likely to be miRNA-targets. (C) Pearson correlation (r) between the residual of the linear model
and the log2(iMir) value as a function of cut-off applied to the posterior probability to be a miRNA
target. A cut-off of zero corresponds to (A), and a cut-off of 4 (solid vertical line) corresponds to (B).
Correlations are shown for subsets for log2 posterior probability cut-offs in 1.0 inter- vals. The point-
size illustrates the number of genes at each cut-off. At 4.9, the subset contains 1000 genes (dashed
line), the subset at 6.2 contains 100 genes (dotted line). Increasing cut-offs select higher-confidence
miRNA-target genes that can explain the residual of the linear fit slightly better.
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3.2.8 Prediction of mRNA abundance change between cell types
Supplemental Figure 3.18: Predictive power of chromatin and hal-life in changes of mRNA. (A)
Scatter plot showing correlation between change predicted transcription rate (x-axis) and change in
measured mRNA level (y-axis), changes from ES to TN respectively. (B) Scatter plot showing corre-
lation between experimen- tally inferred half-life in ES (x-axis) and TN (y-axis). Transcript half-life
changes between the cell types indi- cating a functional importance of RNA decay. (C) Potential of
mRNA half-life changes to explain remaining changes in measured mRNA levels. Similarly to (A),
correlation between changes in transcription (x-axis) and changes in measured mRNA (y-axis), colours
indicate level of change in mRNA half-life. Negative values indicate genes which decrease in half-life
during differentiation. These genes contribute to a decrease in mRNA levels during differentiation.
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3.2.9 Tissue-specific expr.: test of independence or homogeneity
We test here whether ES or TN specific expressed genes are independent of the definition
of tissue-specificity obtained from SymAtlas. Tissue specific expression was defined based
on symAtlas expression over 75 tissues. For each refSeq gene we counted the number of
tissues/cell types in which it is expressed (expression defined by a cut-off in log-transformed
expression, exp > 7). RefSeqs are then classified accruing to the number of tissues in not
expressed (0 tissues), tissues-specific expressed (1-5 tissues), intermediate (6-70 tissues)
and ubiquitous expressed (71-75 tissues). ES or TN specific expression was defined given
the mRNA sequencing data in our differentiation system, comparing ES and TN. We clas-
sified into expressed in [ES AND TN] or [ES OR TN] by a cut-off at +/ − 2 from the
x = y diagonal. Based on these groups we tested the if tissue-specific expression accruing
to symAtlas is independent to the expression pattern observed in our system. We use the
following matrix to perform a chi-squared test:
tissues-specific ubiquitous
ES or TN 279 661
ES and TN 386 2019
.
The p-value obtained is close to zero ( < 2.2e − 16). Hence we reject the hypothesis
that the expression type according to symAtlas is the same for genes expressed in either or
both of our cells types. Looking at the data, ubiquitous expressed genes are more enriched
in genes expressed in both cell types.
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3.2.10 A partially non-linear model
In a linear setting we have:
Ti = a0 +
∑
j
ajCij (3.61)
where Cij are measured chromatin modifications of type j for gene i and aj are the cor-
responding coefficients of the multilinear regression. The fitted response (mRNA level) is
sigmoidal distorted (Figure 13, left).
σ(x) = sigmoid(a0 +
∑
j
ajCij) (3.62)
where σ(x) is a sigmoidal function that captures the distortion of the linear relationship due
the detection limit at the lower end and due to the saturation of 3K36me3 at the upper
end of the mRNA levels. One of the simplest sigmoidal functions is:
σ(x) = c+
d− c
1 + exp(b ∗ (x− e) (3.63)
It has the simple inverse:
σ¯(y) = e+
1
b
∗ log(−d+ y
c− y ) (3.64)
where e is the position of the largest inflection, b is the slope there.
However, inSig is only defined between the saturation levels c and d. If we want to
fit all our datapoints, some of which will be outside these boundaries, we have to use a
complex function composed of an inverse sigmoid with a linear function attached to each
side of the inverse sigmoid. For that we introduce a fifth parameter, δ that determines the
’attachment point’ of these linear functions relative to the left and right boundaries c and
d of the inverse sigmoid. The formula for the composite function can be written as:
σ¯(x)∗(b, c, d, e, δ) =

mx+ n, if x <= c+ δ
mx+ n, if x >= d− δ
e+ 1b ∗ log(−d+xc−x ), else
(3.65)
where the slope m of the ’attached’ linear functions is the first derivative of σ¯(x) at (c+ δ)
and (d − δ). The y-intercept n for each of the linear functions can be calculated from x,
m and σ¯(x).
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Using a range of starting parameters for b, c, d, e and δ we do a non-linear model fitting.
In case the nls converges, it always converges with the parameters b = −16.39, c = 0.49,
d = 0.87, e = 0.5 and δ = 0.07 (see Figure 13, left).
Indeed, the lower mRNA levels seem to relate linear to the predicted transcription, whereas
the sigmoid distortion is detected only in a small intervall. TThe normalized covariance
between the measured mRNA levels and the predicted transcription values after transfor-
mation by the inverse sigmoidal function is only marginally larger than for the linear fit (see
Figure 13, 0.846 vs. 0.851).
Supplemental Figure 3.19: Non-linear fitting of a composite function to the data, predicted tran-
scription vs. measured mRNA. Left: A non-linear model composed of an inverse sigmoid with linear
functions attached is fitted. The orange line shows the composite function. The green lines indicate
the range of the invese sigmoid in the x-axis and the inflection point on the y-axis. Right: Predicted
transciption was transformed accoding to the composite function and plotted against mRNA again.
Explained variance of mRNA by original and transformed predicted transcription is shown above the
plots respectively.
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3.2.11 Additional supplemental figures
Supplemental Figure 3.20: Scatter plot of linear-model derived transcription rate (x-axis) and mea-
sured mRNA levels (y-axis). Both are log2 transformed read-counts. In additon to pearson correlation,
we also show kendall and spearman correlations and corresponding p-values to show the significance of
the high correlation between the two values despite their non-normal distribution.
Supplemental Figure 3.21: Scatter plots show correlation of the regressors in the linear model (histone
modifications) with half-life. Shown are the respective regressors on the x-axes and half-life of the
corresponding transcript on the y-axes.
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Supplemental Figure 3.22: Bar plot represents the correlation (r) of different post-transcritional
measures with the residual of the linear model. For mRNA half-life measurements by metabolic labeling
(HL.thioU), as well as for the measures of being a miRNA target, pearson correlation was tested by
bootstrapping using the repective contiuous variables. For the mRNA half-life measure derived by
actinomycinD treatment (HL.actiD) we use a categorical variable (due to group of long lived genes)
and infer r by linear regression. In all cases, error bars represent 95% confidence interval, p-value
respectively for each test.
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Supplemental Figure 3.23: Mapability of mRNA-sequencing reads. Foreach refSeq transcript a
mapability score m was calculated as the ratio of uniquely mapable over all 36mer sequences of
that transcript. To calculate mapablity of 36mers, each transcript was tiled in n 36mers, where
n = lengthtranscript− 35. All 36mes were aligned to the mm9 genomic sequences as well as to refSeq
transcripts and defined as unique if it did not match more than once in either of the references. The
distribution of m is shown in the density plot on the left, inset plot contains only m! = 1. The scatter
plot on the right shows the distribution of non-uniquely mapping transcripts (lower 5%, m <0.79)
within the population of all representative transcripts.
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Chapter 4
Conclusions
In the past 5 years much progress has been made understanding the mechanisms that in-
fluence steady-state or dynamic mRNA level at the level of chromatin, transcription or on
the post-transcriptional level. However an integrated view of all these layers is needed to
understand the interplay and relative contributions to gene expression in a cell.
At the beginning of my PhD thesis there were no genome-wide studies on global contribu-
tions of transcription, mRNA stability and other factors to mRNA levels [Cheadle et al.,
2005] and my aim was to integrate genome-wide chromatin data available in the lab with
measures of post-transcriptional regulation to determine the relative contributions of these
layers to steady state mRNA levels. We found that the lion share of steady state mRNA
level is set on the transcriptional level, and post-transcriptional contributions are quanti-
tatively minor. Additionally, we describe histone marks, especially the co-transcriptional
histone mark H3K36me3, as very good predictors of mRNA abundance in the cell.
In the following sections I would like to discuss our findings in the context of recent studies,
published during the time-period of my PhD. These recent studies on the one hand make
use of global measurements of numerous genomic features and attempt to predict mRNA
abundance and on the other hand integrate different regulatory layers into a network ex-
plaining the connectivity in gene expression regulation.
Gene regulation in a broad sense however, goes from DNA not only until mRNA levels
but ultimately to protein levels. Recent developments in quantitative mass spectrometry
opened possibilities to measure protein abundance on a genome-wide scale allowing for the
first time global comparisons of mRNA and protein level and consequently regulatory impact
of translational and post-translational mechanism. I will also discuss some of those findings
and how the results of my PhD project can be interpreted in light of these new developments.
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4.1 A Longstanding Task: Decoupling Regulatory Layers
In my PhD project I asked the question: If regulation of gene expression in eukaryotes is a
stepwise, multi-layered process, what are the relative contributions of these layers? What
are the actual numbers as percentage from ’total’ 100% determination of the steady state
mRNA level?
To address this question we had to separate at least two layers: the transcriptional regula-
tion, ’what get’s transcribed and how efficient?’, and the post-transcriptional regulation, as
’how long is the life-time of the initial transcript?’. To estimate what is being transcribed in
the fist place, there are various methods. The most straightforward approach would be to
monitor ongoing transcription directly, for which nuclear run-on (NRO) would be the closest
method to do so [Garc´ıa-Mart´ınez et al., 2004]. By pulse-labeling, one can integrate the
labeled mRNA over time and have a readout what was transcribed [Garc´ıa-Mart´ınez et al.,
2004]. By integration of a modified, radiolabeled nucleotides, intensities can be detected on
a blot, however, it does not allow for quantitative readout by microarray or deep-sequencing.
Other, less direct, methods try to infer transcription from different genomic features: DNA
sequence itself was shown to be predictive for gene expression. Predicted TF binding sites
and their evolutionary conservation have been used to infer promoter activity [Hemberg and
Kreiman, 2011; Irie et al., 2011]. But DNA sequence not only provides binding specificity for
TFs but also largely determines nucleosome positioning [Segal et al., 2006]. DNA binding
complexes, nucleosomes, TFs and the recruited RNAP II transcription machinery compete
for binding around promoter regions and one can calculate probabilities of transcription
initiation at promoters based on thermodynamic equilibrium (reviewed in Segal and Widom
[2009]). However, experimentally derived TF binding makes a much better predictor [Cheng
and Gerstein, 2011] since only a subset of predicted TF binding sites will be actually occu-
pied in vivo. In the same line experimentally inferred histone modification data provides a
powerful prediction of mRNA abundance of the linked gene. Several studies build on the
histone modification maps in human T cells [Barski et al., 2010; Wang et al., 2008] and
inferred patterns of histone modifications characteristic for actively transcribed promoters
[Hon et al., 2009]. Based on this data the levels of histone modifications were found to
be predictive for both protein-coding mRNA expression, depending on CpG density of the
promoter [Karlic et al., 2010] and even for miRNA expression [Zhang and Zhang, 2011].
Notably, all of these studies restrict their readout of histone modification on a region around
the TSS and thereby miss the high predictive power H3K36me3 in transcription elongation.
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Moreover they find that a few histone modifications are sufficient to predict mRNA levels
and that adding more histone marks does not improve modeling significantly.
We choose to monitor RNAP II together with a few histone marks, that are bi-uniquely
connected with either active of repressed genes. In particular however, we do not restrict
our analysis to the promoter region of the gene, where initiation is regulated but instead
use a more downstream readout which is set during transcription elongation: H3K36me3.
As reviewed in the introduction, this mark is set by the elongating polymerase and stays
and accumulates until it gets diluted by cellular division. Therefore to measure H3K36me3
is actually more informative than RNAP II occupancy itself because RNAP II is only catch-
and detectable at the promoter or in the moment when it ’runs’ through the gene body. It is
also the closest measure in terms of direct readout of transcription without using an invasive
labeling method, IP on chromatin of normal grown cells is sufficient and enrichments yield
high specificity. The variance in mRNA levels, which can be explained by H3K36me3 alone
is therefore already higher than some of the complex predictors used in other studies.
Based on being able to predict more than 80% variance in mRNA levels by 3 histone marks
and RNAP II occupancy, we inferred RNA decay rates transcriptome wide with two different
methods (detailed in the introduction) and found, that although mRNA decay is measurable
in terms of transcript abundance, it only shapes the steady-state level of an mRNA very
little. The percentage contribution we assigned to RNA decay modulating mRNA levels is
between 2 and 12%.
At the beginning of my PhD there was no study addressing the actual quantitative contri-
butions of the different regulatory layers to mRNA levels with high throughput methods.
The first systematic account to this question used transcription run-on (TRO) involving
isolation of nuclei to measure ongoing transcription [Garc´ıa-Mart´ınez et al., 2004]. RNA
stability can then be calculated from mRNA levels and measured transcription rate. In
yeast, Garcia-Martinez et al. found the median pearson correlation (r) of mRNA levels with
transcription is 0.6 while r with mRNA stability is -0.24 and concluded that transcription is
the main determinant of RNA levels. The first study in higher eukaryotes measured changes
in both, transcription and mRNA half-life, during T cell activation in [Cheadle et al., 2005].
Using the same method as [Garc´ıa-Mart´ınez et al., 2004], they observe a lack of detectable
transcriptional regulation (change in newly transcribed RNA) of large numbers of changing
mRNA levels and speculate that mRNA stability may account for as much as 50% of all
changes in mRNA measured. However, this conclusion is largely driven by possible technical
shortcomings of NRO (transcription in isolated nuclei) that bias the measurement and lead
to a reduced correlation with mRNA level changes. To circumvent the downfalls of NRO,
it is possible to measure mRNA decay directly as opposed to inferring it from transcription,
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for example by RNAP II inhibition. A study in yeast showed the response of mRNA abun-
dance and decay under different stress conditions and found that, depending on the type
of stress (transient or enduring) RNA half-life can explain different amounts of changes in
mRNA levels [Shalem et al., 2008]. Many following publications used the same method to
infer mRNA half-life resulting in partially different conclusions (see further down). Using
inhibition of RNAP II, or transcription arrest has the major problem, that the expression
pattern of the cell will potentially change due to the effect of the stress imposed by arresting
transcription.
Two studies in mouse cells recently revisited the question of relative contributions of differ-
ent layers to gene expression [Rabani et al., 2011; Schwanha¨usser et al., 2011]. Both studies
used the less invasive method of metabolic labeling [Do¨lken et al., 2008] to measure tran-
scription and calculate mRNA degradation. In contrast to our study, where transcription
is modelled and half-life is experimentally measured, Rabani et al. measured transcription
directly. Based on measured transcription and mRNA levels, the researchers test two dif-
ferent models: (I) assuming constant degradation for all gene their model can explain 78%
of the variance in mRNA levels whereas a model (II) allowing gene dependent decay rates,
has the capacity to explain 86% variance. This result is consistent with our findings and
although using a different approach, almost yields the same percentages of relative contri-
bution. This is equally consistent with the study by Schwannha¨user et al. [Schwanha¨usser
et al., 2011] which also predicts a minor contribution of mRNA degradation to steady-state
levels and goes even a step further to predict relative regulatory contributions to protein
levels (detailed discussion in section 4.3)
4.2 The Difficulty: Coupling of Regulatory Layers
The main idea of my thesis is based on the assumption that a decoupling of regulatory
layers is fair and possible, because only if they do not depend on each other, we can assess
the relative contribution of each layer.
In yeast, however, there is evidence for a direct coupling mechanism between mRNA tran-
scription and degradation, mediated by two RNAP II subunits: Rpb4 and Rpb7. These
subunits bind to the mRNA during transcription and escort the transcript from the nu-
cleus to the cytoplasm. Thereby they can affect mRNA stability and modulate translation
[Goler-Baron et al., 2008; Lotan et al., 2005, 2007]. Another complex linking production
and degradation is CCR4-NOT, the major mRNA deadenylase in yeast, which controls the
initial step of degradation (see introduction) [Chen et al., 2002; Tucker et al., 2001]. In
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addition it is part of a multicomponent assembly containing diverse transcription initiation
factors, such as members of the SAGA complex [Benson et al., 1998], subunits of RNAP
II [Liu et al., 2001] and subunits of the transcription initiation factor TFIID [Lemaire and
Collart, 2000; Sanders et al., 2002].
Most of the studies on coupling so far have been undertaken in yeast, because a lot is known
about the proteins involved in a possible connection between transcription and degradation.
Two principally different models of interconnection between transcription and degradation
emerged, which I will refer to as ’co-operative’ and ’non-co-operative’ models. In the co-
operative model transcription and degradation act in concert to achieve higher or lower
levels of a certain mRNA, meaning if transcription rate of an mRNA is increased, it would
also be stabilized post-transcriptionally. In the ’non-co-operative’ model mRNA would be
in contrast destabilized when transcriptionally induced. This would result in a ’balancing’
mechanism where transcription and degradation ’buffer’ each other to stabilize a certain
level of mRNA abundance.
All studies on this topic where published within the last 3 years of my PhD, and show
partially contradicting results. Evidence for the cooperative model comes from two studies
in fission and bakers yeast, which monitor transcription by labeling with newly transcribed
RNA with either 4sU [Amorim et al., 2010] or radioactive UTPs [Castells-Roca et al., 2011].
In response to heat shock Castells-Roca et al. found that changes in transcription rates
and mRNA stabilities are mostly homo-directional, meaning induced transcription leads to
higher stability of the mRNA. A similar observation was reported by Amorim et al. in in-
duced meiotic differentiation of S.pombe. Here, the positive link between transcription and
stability was shown to be a TF inducing the production of a stabilizing RBP Meu5p along
with other genes, which are stabilized by Meu5p in the cytoplasm.
A cooperative mechanism would be advantageous in terms of an economic strategy for
gene expression regulation. If in a specific steady-state low levels of an mRNA are sufficient
a homo-directional regulation would similarly produce few mRNA, to avoid unnecessary
degradation of wastefully produced transcript. However in cells of higher eukaryotes the en-
ergy spend to synthesize mRNA in terms of high energy phosphates is roughly one tenth of
the energy consumption by translation [Schwanha¨usser et al., 2011]. Therefore the cellular
energy usage in transcription and post-transcriptional processes might not be a driving force
to select a way of regulatory interaction. However the cooperative model may be sensible
in terms of responsiveness to environment. If transcription and degradation of mRNA are
able to act in concert to achieve higher or lower mRNA levels adaption to external stimuli
will be fast.
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Evidence for the non-cooperative model comes from both, yeast but also mammalian sys-
tems. When transcription and degradation are able to counter act, and thereby balance
each other, noise is minimized when a precise level of expression is required.
Monitoring mRNA levels and decay rates in yeast under hyperosmotic stress conditions,
Molin et al. observe genes with decreased transcription are stabilized in the cytoplasm
while stress induced genes undergo destabilization [Molin et al., 2009]. This way the cell
achieves a balancing effect, where final mRNA levels are changed only minimally. A sim-
ilar effect was observed in yeast under oxidative stress [Shalem et al., 2011]: A wild type
yeast could balance mRNA levels by a counteracting response in RNA stability, however a
mutant strain, carrying a RNAP II, that poorly recruits Rpb4 and Rpb7, can not buffer the
change in transcription. This is another evidence for the two RNAP II subunits Rpb4/Rpb7
being involved in coupling between transcription and degradation. Also in favor of the
non-cooperative model is a study by Elkon et al. [Elkon et al., 2010] based on mRNA tran-
scription data in mouse fibroblasts [Do¨lken et al., 2008]. As a response to interferons the
mRNA stability is modulated according to the rapidity of gene induction: a higher induction
leads to shorter half-life.
Within the last year two studies posed the question, if transcription and degradation ap-
pear to be coupled between conditions, is there an evolutionary connection between the
two processes? Therefore they used two related yeast species respectively to investigate
fold-changes in RNA synthesis and decay. Both studies, although using different techniques
to infer mRNA decay, come to the same conclusion: there is coupled evolution between
synthesis and decay [Dori-Bachash et al., 2011; Sun et al., 2012]. Moreover, Sun et al.
used mutants of either RNAP II or the deadenylase Ccr4-Not and found that besides the
expected decrease in transcription or degradation, the counteracting mechanism was buffer-
ing the mRNA levels respectively.
A previous paper from the same lab [Miller et al., 2011] investigating stress response in
yeast, had shown that the interplay between mRNA synthesis and decay is largely depen-
dent on the phase of the stress response. While there was non-cooperative behavior in the
initial shock and induction phase, no correlation between production and degradation was
observed.
With the data derived from our murine in vitro differentiation system, we see that predicted
transcription at a single time point agrees with the non-cooperative model in that highly
transcribed genes (high H3K36me3) are degraded fast and lowly transcribed genes have a
long half-life (correlation of predicted transcription vs. degradation, r = 0.36 ). Based on
the contradicting observations in yeast stress responses, it would be interesting to inves-
tigate how mRNA transcription and degradation rates change upon an external stimulus
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to ESC or terminal neurons. Proteins like Rpb4/Rpb7 exist in mammals and it should be
subject to investigation in the future if these proteins similarly build a physical link between
transcriptional and post-transcriptional regulation.
4.3 mRNA to Protein
A key assumption in studying mRNA expression is that it is informative for the prediction of
protein abundance. However, only recently studies have explored the mRNA-protein expres-
sion correlation in yeast or human tissues and the results have been relatively inconsistent
[Guo et al., 2008].
Two early studies in yeast [Griffin et al., 2002; Gygi et al., 1999], which assessed this
correlation, where restricted to a very low number of genes (< 250) due to the laborious
work of mass spectrometry. Looking at steady state [Gygi et al., 1999] and fold-changes
between yeast growth conditions [Griffin et al., 2002] both groups found a very low corre-
lation between mRNA and protein. Apart from the low number of monitored genes, mass
spectromety itself is thought to be difficult for quantitative studies because the efficiency
with which peptides ionize and enter the mass spectrometer depends upon both their com-
position and the local chemical environment, producing variation in the MS signal intensity
[Lu et al., 2007]. Lu et al., also in yeast, used a method to normalize for this effect (APEX)
and found that 73% of the protein abundance is explained by mRNA abundance. This
high correlation was confirmed by another lab which imposed osmotic stress on yeast and
measured abundance of about 2500 proteins together with their coding mRNAs (pearson
correlation = 0.87, Lee et al. [2011]).
Moreover, studies in mammalian systems are also in disagreement whether mRNA levels
reflect protein abundance in a cell. Three studies in human monocytes [Guo et al., 2008],
murine ES [Lu et al., 2009] and liver [Ghazalpour et al., 2011] cells report that a large pro-
portion of changes in protein levels is not accompanied by analog changes in the expression
of corresponding mRNAs, suggesting an important role for translational regulation. On the
other hand, results in human cancer cell lines [Nagaraj et al., 2011; Vogel et al., 2010],
which monitored up to 9207 genes by RNA-sequencing and microarrays and corresponding
proteins levels, report a higher correlation ranging from 0.53 to 0.6. In human ESC, induced
pluripotent stem cells and fibroblasts, the reported explained variance of protein by mRNA
level was even higher (r=0.7, Munoz et al. [2011]).
Recent studies using the SILAC method (stable isotope labeling by amino acids in cell cul-
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ture) to quantify protein abundance and sequencing to quantify mRNA abundance are in
good agreement with a correlation between the two measures of more than 0.6 [Lundberg
et al., 2010; Schwanha¨usser et al., 2011].
In my PhD thesis I do not investigate the abundance of proteins at all and just ask whether
transcription, or features related to transcription are predictive for mRNA levels. Following
these more recent studies, which report a high correlation between mRNA and protein, our
results would implicate that one can fairly estimate the actual protein output of a cell by
measuring histone marks and RNAP II abundance alone. Many studies investigating mRNA
levels, implicitly assume a high correlation to protein and extrapolate their findings the be
relevant for the phenotype of the cell. This is challenged by reports showing a low explained
variance of proteins on the mRNA level [Ghazalpour et al., 2011; Guo et al., 2008; Lu et al.,
2009]. From the current knowledge and ongoing discrepancy about contributions to pro-
tein levels, and in the scope of my PhD project it would be too speculative to extrapolate
to protein levels and phenotype but it would be an inevitable next step to investigate the
quantitative contribution of chromatin marks not only to mRNA but to protein abundance.
4.4 Modeling in Biology
In my PhD thesis I attempt to explain the relative contributions of different regulatory lay-
ers in gene expression regulation to mRNA levels in a given cell. The last three conclusion
chapters extend this aim in summarizing studies which investigate not only quantitative
contributions but also the coupling between the regulatory processes. Some studies (sec-
tion 4.3) even go further in trying to explain protein levels which implies the consideration
of even more regulatory processes. The final goal of collecting this information on relation-
ships between process is to build an abstract model which simplifies the complex biological
processes. In general, an abstract scientific model can help to explain a system, to study
the effects of different components, and to make predictions about unobserved data points.
A statistical model, like the linear model used in my thesis, is a formalization of the rela-
tionships between variables in the form of mathematical equations.
Mathematical models can be classified differently, one of which is the distinction between
deterministic and probabilistic (stochastic) models. A deterministic model is one in which
every set of variable states is uniquely determined by parameters in the model and by sets
of previous variable states. A stochastic model does not describe variables by unique values
but rather by probability distributions. Due to the brownian motion in a cell for exam-
ple, randomness is present and a stochastic model would likely reflect the situation better.
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However, deterministic models always perform the same way for a given set of initial con-
ditions, which is preferable when we want to make predictions. Amongst other possible
classifications of models, we choose to use linear over non-linear models to describe our
system. There may be cases where one can through biological reasoning assume linearity,
as an example one could assume that one RNAP II produces 5 mRNAs/h, two RNAP II
produce 10 mRNAs/h and so on. This would imply a linear relationship between RNAP
II and the amount of mRNA produced. However in most cases this relationships between
elements in a biological system are not known because quantitative measures are hard to
obtain or vary largely either between molecules in a cell, between cells within a population
or between replicates within an experiment. In our case we use the most simple model: a
linear model.
Linear modeling, or linear regression, as introduced in the first chapter, was coined in the
18th century, where it was applied to observations about properties of peas and people
[Galton, 1890]. At this time however, to make a single linear regression on a larger set of
data could take days to solve manually. With the rapid development of computing in terms
of memory and performance in the last decades regression problems for many data intensive
purposes, such as in economics, are solved computationally. Since biological readout turned
from ’blobs on films’ to quantitative measurements, regression models started to find their
application in this field, too. The advent of high-throughput methods for data quantifica-
tion such as microarrays or deep-sequencing in the 1990s allowed parallel investigation of
thousands of genes. Bringing together computational and technological advance enables us
now to employ modeling on a new level. Due to the large amount of data, we can actually
visualize if the relationship between two biological variables, is linear, or non-linear. We
obtained measurements for more than 10.000 genes and visualized predicted transcription
based on enrichment of histone modifications in relation to transcript abundance of the
respective gene. From the scatter plot we can conclude that the relationship between the
log-transformed values of these readouts is almost linear, which led us to employ linear
regression. The non-linear behavior on the upper and lower end of the predicted transcrip-
tion can be explained by the technical limitations of ChIP for a histone mark. We tried
to account for this systematic deviation from the linear regression line by implementing a
more complex model, composed of a linear and an inverse sigmoid part. Fitting the complex
model to the data revealed that it is not much more powerful in predicting mRNA levels
from histone modification data. In general, model complexity always involves a trade-off
between simplicity and accuracy of the model. We therefore applied a principle particularly
relevant to modeling, the essential idea being that among models with roughly equal pre-
dictive power, the simplest one is the most desirable (known as ’Occam’s razor’). While
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added complexity usually improves the predictive power of a model, it can make the model
more difficult to interpret. In the special case of a linear model we can even conclude from
the correlation coefficient to the explained variance, and coefficients of the predictors will
return contributions to the explained variance. This is not possible with a non-linear model,
therefore we chose the advantage of simplicity over the little improvement in explanatory
power.
With models built on experimentally inferred high trough-put data from biological systems
researchers can now start to investigate if concepts developed from single gene analyses
hold true on genome wide level. Modeling allows us to reevaluate with a large amount of
datapoints and potentially change these concepts on the way to understand gene regulation
as a whole process. This follows the idea that natural systems and their properties, should
be viewed as wholes, not as collections of parts. This holistic way of scientific research is
reflected in the relatively young discipline of systems biology and will mostly be driven by
the application of different modeling approaches.
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Acronyms
ARE AU rich element.
ChIP chromatin immunoprecipitation.
CTD carboxyl-terminal domain.
EEC early elongation complex.
EJC exon junction complex.
GTF general transcription factor.
H3K27me3 tri-methylation of lysine 27 at hi-
stone tail H3.
H3K36me3 tri-methylation of lysine 36 at hi-
stone tail H3.
H3K4me2 di-methylation of lysine 4 at histone
tail H3.
HIV human immunodeficiency virus.
HMT histone methyl-transferase.
hnRNPL heterogenous ribonucleoprotein L.
IRES internal ribosome entry site.
ITC initially transcribing complex.
LMR low methylated region.
MBD methyl-CpG-binding domain protein.
MES-4 maternal effect sterile 4.
MET-1 histone-methyltransferase-like 1.
miRISC miRNA induced silencing complex.
miRNA micro RNA.
mRNA messenger RNA.
mRNP messenger ribonucleoproteins.
NPC nuclear pore complex.
NSD1 nuclear receptor binding SET domain
protein 1.
P-TEFb positive transcription-elongation
factor-b.
PIC pre-initiation complex.
PTM post-translational modifications.
RBP RNA binding protein.
RNAP II RNA polymerase II.
Rpb1 large subunit of RNAP II.
Set2 SET domain-containing.
SETD2 SET domain-containing 2.
snRNP small nuclear RNP.
SR serine/arginine-rich.
TBP TATA binding protein.
TF transcription factor.
TSS transcription start site.
UTR un-translated region.
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